-
2
-
-
53249123632
-
-
Lyon, France, International Agency for Research on Cancer
-
Swerdlow SH, Campo E, Harris NL, et al (eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France, International Agency for Research on Cancer, 2008
-
(2008)
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
-
-
Swerdlow, S.H.1
Campo, E.2
Harris, N.L.3
-
3
-
-
0036206437
-
Hodgkin's lymphoma: The pathologist's viewpoint
-
Pileri SA, Ascani S, Leoncini L, et al: Hodgkin's lymphoma: The pathologist's viewpoint. J Clin Pathol 55:162-176, 2002 (Pubitemid 34250900)
-
(2002)
Journal of Clinical Pathology
, vol.55
, Issue.3
, pp. 162-176
-
-
Pileri, S.A.1
Ascani, S.2
Leoncini, L.3
Sabattini, E.4
Zinzani, P.L.5
Piccaluga, P.P.6
Pileri Jr., A.7
Giunti, M.8
Falini, B.9
Bolis, G.B.10
Stein, H.11
-
4
-
-
4544247638
-
Hodgkin's lymphoma: Biology and treatment strategies for primary, refractory, and relapsed disease
-
Diehl V, Stein H, Hummel M, et al: Hodgkin's lymphoma: Biology and treatment strategies for primary, refractory, and relapsed disease. Hematology Am Soc Hematol Educ Program 225-247, 2003
-
(2003)
Hematology Am Soc Hematol Educ Program
, pp. 225-247
-
-
Diehl, V.1
Stein, H.2
Hummel, M.3
-
5
-
-
0032548107
-
A prognostic score for advanced Hodgkin's disease: International Prognostic Factors Project on Advanced Hodgkin's Disease
-
Hasenclever D, Diehl V: A prognostic score for advanced Hodgkin's disease: International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med 339:1506-1514, 1998
-
(1998)
N Engl J Med
, vol.339
, pp. 1506-1514
-
-
Hasenclever, D.1
Diehl, V.2
-
6
-
-
77956646155
-
Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma
-
Engert A, Plutschow A, Eich HT, et al: Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. N Engl J Med 363:640-652, 2010
-
(2010)
N Engl J Med
, vol.363
, pp. 640-652
-
-
Engert, A.1
Plutschow, A.2
Eich, H.T.3
-
7
-
-
77949355797
-
Toward a personalized treatment of Hodgkin's disease
-
DeVita VT Jr, Costa J: Toward a personalized treatment of Hodgkin's disease. N Engl J Med 362:942-943, 2010
-
(2010)
N Engl J Med
, vol.362
, pp. 942-943
-
-
DeVita Jr., V.T.1
Costa, J.2
-
8
-
-
0037097818
-
The role of cytokines in classical Hodgkin lymphoma
-
DOI 10.1182/blood-2002-01-0099
-
Skinnider BF, Mak TW: The role of cytokines in classical Hodgkin lymphoma. Blood 99:4283-4297, 2002 (Pubitemid 34627193)
-
(2002)
Blood
, vol.99
, Issue.12
, pp. 4283-4297
-
-
Skinnider, B.F.1
Mak, T.W.2
-
10
-
-
33645227964
-
Epstein-Barr virus, cytokines, and inflammation: A cocktail for the pathogenesis of Hodgkin's lymphoma?
-
Khan G: Epstein-Barr virus, cytokines, and inflammation: A cocktail for the pathogenesis of Hodgkin's lymphoma? Exp Hematol 34:399-406, 2006
-
(2006)
Exp Hematol
, vol.34
, pp. 399-406
-
-
Khan, G.1
-
11
-
-
0033952886
-
Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease
-
Dukers DF, Jaspars LH, Vos W, et al: Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease. J Pathol 190:143-149, 2000 (Pubitemid 30082486)
-
(2000)
Journal of Pathology
, vol.190
, Issue.2
, pp. 143-149
-
-
Dukers, D.F.1
Jaspars, L.H.2
Vos, W.3
Oudejans, J.J.4
Hayes, D.5
Cillessen, S.6
Middeldorp, J.M.7
Meijer, C.J.L.M.8
-
12
-
-
0027101947
-
Production of multiple cytokines by Hodgkin's disease derived cell lines
-
Klein S, Jucker M, Diehl V, et al: Production of multiple cytokines by Hodgkin's disease derived cell lines. Hematol Oncol 10:319-329, 1992 (Pubitemid 23101130)
-
(1992)
Hematological Oncology
, vol.10
, Issue.6
, pp. 319-329
-
-
Klein, S.1
Jucker, M.2
Diehl, V.3
Tesch, H.4
-
13
-
-
42549166115
-
The CD4+CD26- T-cell population in classical Hodgkin's lymphoma displays a distinctive regulatory T-cell profile
-
DOI 10.1038/labinvest.2008.24, PII LABINVEST200824
-
Ma Y, Visser L, Blokzijl T, et al: The CD4+CD26- T-cell population in classical Hodgkin's lymphoma displays a distinctive regulatory T-cell profile. Lab Invest 88:482-490, 2008 (Pubitemid 351581458)
-
(2008)
Laboratory Investigation
, vol.88
, Issue.5
, pp. 482-490
-
-
Ma, Y.1
Visser, L.2
Blokzijl, T.3
Harms, G.4
Atayar, C.5
Poppema, S.6
Van Den, B.A.7
-
14
-
-
0028961649
-
Interleukin-12 expression in human lymphomas and nonneoplastic lymphoid disorders
-
Schwaller J, Tobler A, Niklaus G, et al: Interleukin-12 expression in human lymphomas and nonneoplastic lymphoid disorders. Blood 85:2182-2188, 1995
-
(1995)
Blood
, vol.85
, pp. 2182-2188
-
-
Schwaller, J.1
Tobler, A.2
Niklaus, G.3
-
15
-
-
0025461832
-
Immunoenzymatic assessment of interferon-gamma in Hodgkin and Sternberg-Reed cells
-
Gerdes J, Kretschmer C, Zahn G, et al: Immunoenzymatic assessment of interferon-gamma in Hodgkin and Sternberg-Reed cells. Cytokine 2:307-310, 1990
-
(1990)
Cytokine
, vol.2
, pp. 307-310
-
-
Gerdes, J.1
Kretschmer, C.2
Zahn, G.3
-
16
-
-
0033560818
-
Differential chemokine expression in tissues involved by Hodgkin's disease: Direct correlation of eotaxin expression and tissue eosinophilia
-
Teruya-Feldstein J, Jaffe ES, Burd PR, et al: Differential chemokine expression in tissues involved by Hodgkin's disease: Direct correlation of eotaxin expression and tissue eosinophilia. Blood 93:2463-2470, 1999 (Pubitemid 29181176)
-
(1999)
Blood
, vol.93
, Issue.8
, pp. 2463-2470
-
-
Teruya-Feldstein, J.1
Jaffe, E.S.2
Burd, P.R.3
Kingma, D.W.4
Setsuda, J.E.5
Tosato, G.6
-
17
-
-
0027278569
-
Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms
-
Kurzrock R, Redman J, Cabanillas F, et al: Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms. Cancer Res 53:2118-2122, 1993 (Pubitemid 23145736)
-
(1993)
Cancer Research
, vol.53
, Issue.9
, pp. 2118-2122
-
-
Kurzrock, R.1
Redman, J.2
Cabanillas, F.3
Jones, D.4
Rothberg, J.5
Talpaz, M.6
-
18
-
-
0033591689
-
Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells
-
Kapp U, Yeh WC, Patterson B, et al: Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells. J Exp Med 189: 1939-1946, 1999
-
(1999)
J Exp Med
, vol.189
, pp. 1939-1946
-
-
Kapp, U.1
Yeh, W.C.2
Patterson, B.3
-
19
-
-
0025021864
-
Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia
-
Samoszuk M, Nansen L: Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia. Blood 75:13-16, 1990 (Pubitemid 20031482)
-
(1990)
Blood
, vol.75
, Issue.1
, pp. 13-16
-
-
Samoszuk, M.1
Nansen, L.2
-
20
-
-
0028309999
-
The nature of Reed- Sternberg cells: Phenotype, genotype, and other properties
-
Hsu SM, Hsu PL: The nature of Reed- Sternberg cells: Phenotype, genotype, and other properties. Crit Rev Oncog 5:213-245, 1994
-
(1994)
Crit Rev Oncog
, vol.5
, pp. 213-245
-
-
Hsu, S.M.1
Hsu, P.L.2
-
21
-
-
0027197741
-
Lymphotoxin, tumour necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases
-
Foss HD, Herbst H, Oelmann E, et al: Lymphotoxin, tumour necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed- Sternberg cells of most Hodgkin's disease cases. Br J Haematol 84:627-635, 1993 (Pubitemid 23248054)
-
(1993)
British Journal of Haematology
, vol.84
, Issue.4
, pp. 627-635
-
-
Foss, H.-D.1
Herbst, H.2
Oelmann, E.3
Samol, J.4
Grebe, M.5
Blankenstein, T.6
Matthes, J.7
Qin, Z.-H.8
Falini, B.9
Pileri, S.10
Diamantstein, T.11
Stein, H.12
-
22
-
-
0026043718
-
Cytokine expression in T-cell lymphomas and Hodgkin's disease: Its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth
-
Merz H, Fliedner A, Orscheschek K, et al: Cytokine expression in T-cell lymphomas and Hodgkin's disease: Its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth. Am J Pathol 139:1173-1180, 1991
-
(1991)
Am J Pathol
, vol.139
, pp. 1173-1180
-
-
Merz, H.1
Fliedner, A.2
Orscheschek, K.3
-
23
-
-
0026048748
-
Interleukin-9 expression in human malignant lymphomas: Unique association with Hodgkin's disease and large cell anaplastic lymphoma
-
Merz H, Houssiau FA, Orscheschek K, et al: Interleukin-9 expression in human malignant lymphomas: Unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood 78:1311-1317, 1991
-
(1991)
Blood
, vol.78
, pp. 1311-1317
-
-
Merz, H.1
Houssiau, F.A.2
Orscheschek, K.3
-
24
-
-
33644840611
-
IL-9 expression contributes to the cellular composition in Hodgkin lymphoma
-
Glimelius I, Edstrom A, Amini RM, et al: IL-9 expression contributes to the cellular composition in Hodgkin lymphoma. Eur J Haematol 76:278-283, 2006
-
(2006)
Eur J Haematol
, vol.76
, pp. 278-283
-
-
Glimelius, I.1
Edstrom, A.2
Amini, R.M.3
-
25
-
-
0029986054
-
Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease
-
Herbst H, Foss HD, Samol J, et al: Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease. Blood 87:2918-2929, 1996 (Pubitemid 26102243)
-
(1996)
Blood
, vol.87
, Issue.7
, pp. 2918-2929
-
-
Herbst, H.1
Foss, H.-D.2
Samol, J.3
Araujo, I.4
Klotzbach, H.5
Krause, H.6
Agathanggelou, A.7
Niedobitek, G.8
Stein, H.9
-
26
-
-
11144233653
-
Expression of the T-cell transcription factors, GATA-3 and T-bet, in the neoplastic cells of Hodgkin lymphomas
-
Atayar C, Poppema S, Blokzijl T, et al: Expression of the T-cell transcription factors, GATA-3 and T-bet, in the neoplastic cells of Hodgkin lymphomas. Am J Pathol 166:127-134, 2005 (Pubitemid 40051666)
-
(2005)
American Journal of Pathology
, vol.166
, Issue.1
, pp. 127-134
-
-
Atayar, C.1
Poppema, S.2
Blokzijl, T.3
Harms, G.4
Boot, M.5
Van Den, B.A.6
-
27
-
-
0035170688
-
Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma
-
DOI 10.1182/blood.V97.1.250
-
Skinnider BF, Elia AJ, Gascoyne RD, et al: Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 97:250-255, 2001 (Pubitemid 32061267)
-
(2001)
Blood
, vol.97
, Issue.1
, pp. 250-255
-
-
Skinnider, B.F.1
Elia, A.J.2
Gascoyne, R.D.3
Trumper, L.H.4
Von Bonin, F.5
Kapp, U.6
Patterson, B.7
Snow, B.E.8
Mak, T.W.9
-
28
-
-
33846238425
-
Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL
-
DOI 10.1182/blood-2006-04-015958
-
Chiu A, Xu W, He B, et al: Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL. Blood 109:729-739, 2007 (Pubitemid 46105975)
-
(2007)
Blood
, vol.109
, Issue.2
, pp. 729-739
-
-
Chiu, A.1
Xu, W.2
He, B.3
Dillon, S.R.4
Gross, J.A.5
Sievers, E.6
Qiao, X.7
Santini, P.8
Hyjek, E.9
Lee, J.-W.10
Cesarman, E.11
Chadburn, A.12
Knowles, D.M.13
Cerutti, A.14
-
29
-
-
0035525784
-
Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines
-
Fiumara P, Snell V, Li Y, et al: Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines. Blood 98:2784-2790, 2001
-
(2001)
Blood
, vol.98
, pp. 2784-2790
-
-
Fiumara, P.1
Snell, V.2
Li, Y.3
-
30
-
-
0034796923
-
Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease
-
DOI 10.1046/j.1365-2141.2001.02977.x
-
Molin D, Fischer M, Xiang Z, et al: Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease. Br J Haematol 114:616-623, 2001 (Pubitemid 32953640)
-
(2001)
British Journal of Haematology
, vol.114
, Issue.3
, pp. 616-623
-
-
Molin, D.1
Fischer, M.2
Xiang, Z.3
Larsson, U.4
Harvima, I.5
Venge, P.6
Nilsson, K.7
Sundstrom, C.8
Enblad, G.9
Nilsson, G.10
-
31
-
-
0034651829
-
Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors
-
von Wasielewski R, Seth S, Franklin J, et al: Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors. Blood 95:1207-1213, 2000 (Pubitemid 30099828)
-
(2000)
Blood
, vol.95
, Issue.4
, pp. 1207-1213
-
-
Von Wasielewski, R.1
Seth, S.2
Franklin, J.3
Fischer, R.4
Hubner, K.5
Hansmann, M.L.6
Diehl, V.7
Georgii, A.8
-
32
-
-
0036110322
-
Common and differential chemokine expression patterns in rs cells of NLP, EBV positive and negative classical Hodgkin lymphomas
-
Maggio EM, Van Den Berg A, Visser L, et al: Common and differential chemokine expression patterns in rs cells of NLP, EBV positive and negative classical Hodgkin lymphomas. Int J Cancer 99:665-672, 2002
-
(2002)
Int J Cancer
, vol.99
, pp. 665-672
-
-
Maggio, E.M.1
Van Den Berg, A.2
Visser, L.3
-
33
-
-
0026597091
-
In situ expression of the IL-1-alpha and TNF-alpha genes by Reed-Sternberg cells in Hodgkin's disease
-
Xerri L, Birg F, Guigou V, et al: In situ expression of the IL-1-alpha and TNF-alpha genes by Reed-Sternberg cells in Hodgkin's disease. Int J Cancer 50:689-693, 1992
-
(1992)
Int J Cancer
, vol.50
, pp. 689-693
-
-
Xerri, L.1
Birg, F.2
Guigou, V.3
-
34
-
-
0025363317
-
Tumor necrosis factor alpha and lymphotoxin production in Hodgkin's disease
-
Kretschmer C, Jones DB, Morrison K, et al: Tumor necrosis factor alpha and lymphotoxin production in Hodgkin's disease. Am J Pathol 137:341-351, 1990 (Pubitemid 20232995)
-
(1990)
American Journal of Pathology
, vol.137
, Issue.2
, pp. 341-351
-
-
Kretschmer, C.1
Jones, D.B.2
Morrison, K.3
Schluter, C.4
Feist, W.5
Ulmer, A.J.6
Arnoldi, J.7
Matthes, J.8
Diamantstein, T.9
Flad, H.-D.10
Gerdes, J.11
-
35
-
-
0023263077
-
Anti-interleukin-1 reactive cells in Hodgkin's disease
-
DOI 10.1002/1097-0142(19870515)59:10<1717::AID-CNCR2820591007>3.0. CO;2-U
-
Ree HJ, Crowley JP, Dinarello CA: Anti-interleukin- 1 reactive cells in Hodgkin's disease. Cancer 59:1717-1720, 1987 (Pubitemid 17075416)
-
(1987)
Cancer
, vol.59
, Issue.10
, pp. 1717-1720
-
-
Ree, H.J.1
Crowley, J.P.2
Dinarello, C.A.3
-
36
-
-
0027513352
-
Abundant expression of transforming growth factor-beta1 and -beta2 by Hodgkin's Reed-Sternberg cells and by reactive T lymphocytes in Hodgkin's disease
-
DOI 10.1016/0046-8177(93)90034-E
-
Hsu SM, Lin J, Xie SS, et al: Abundant expression of transforming growth factor-beta 1 and -beta 2 by Hodgkin's Reed-Sternberg cells and by reactive T lymphocytes in Hodgkin's disease. Hum Pathol 24:249-255, 1993 (Pubitemid 23086359)
-
(1993)
Human Pathology
, vol.24
, Issue.3
, pp. 249-255
-
-
Hsu, S.-M.1
Lin, J.2
Xie, S.-S.3
Hsu, P.-L.4
Rich, S.5
-
37
-
-
13544271150
-
The role of interleukin-3 in classical Hodgkin's disease
-
DOI 10.1080/10428190400013712
-
Aldinucci D, Olivo K, Lorenzon D, et al: The role of interleukin-3 in classical Hodgkin's disease. Leuk Lymphoma 46:303-311, 2005 (Pubitemid 40220389)
-
(2005)
Leukemia and Lymphoma
, vol.46
, Issue.3
, pp. 303-311
-
-
Aldinucci, D.1
Olivo, K.2
Lorenzon, D.3
Poletto, D.4
Gloghini, A.5
Carbone, A.6
Pinto, A.7
-
38
-
-
0036169090
-
Expression of functional interleukin-3 receptors on Hodgkin and Reed-Sternberg cells
-
Aldinucci D, Poletto D, Gloghini A, et al: Expression of functional interleukin-3 receptors on Hodgkin and Reed-Sternberg cells. Am J Pathol 160:585-596, 2002 (Pubitemid 34160336)
-
(2002)
American Journal of Pathology
, vol.160
, Issue.2
, pp. 585-596
-
-
Aldinucci, D.1
Poletto, D.2
Gloghini, A.3
Nanni, P.4
Degan, M.5
Perin, T.6
Ceolin, P.7
Rossi, F.M.8
Gattei, V.9
Carbone, A.10
Pinto, A.11
-
39
-
-
1242338864
-
Expression of CCL28 by Reed-Sternberg Cells Defines a Major Subtype of Classical Hodgkin's Disease with Frequent Infiltration of Eosinophils and/or Plasma Cells
-
Hanamoto H, Nakayama T, Miyazato H, et al: Expression of CCL28 by Reed-Sternberg cells defines a major subtype of classical Hodgkin's disease with frequent infiltration of eosinophils and/or plasma cells. Am J Pathol 164:997-1006, 2004 (Pubitemid 38235481)
-
(2004)
American Journal of Pathology
, vol.164
, Issue.3
, pp. 997-1006
-
-
Hanamoto, H.1
Nakayama, T.2
Miyazato, H.3
Takegawa, S.4
Hieshima, K.5
Tatsumi, Y.6
Kanamaru, A.7
Yoshie, O.8
-
40
-
-
41349119388
-
Proteomics analysis of Hodgkin lymphoma: Identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes
-
DOI 10.1182/blood-2007-09-112128
-
Ma Y, Visser L, Roelofsen H, et al: Proteomics analysis of Hodgkin lymphoma: Identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes. Blood 111:2339-2346, 2008 (Pubitemid 351451442)
-
(2008)
Blood
, vol.111
, Issue.4
, pp. 2339-2346
-
-
Ma, Y.1
Visser, L.2
Roelofsen, H.3
De Vries, M.4
Diepstra, A.5
Van Imhoff, G.6
Van Der, W.T.7
Luinge, M.8
Alvarez-Llamas, G.9
Vos, H.10
Poppema, S.11
Vonk, R.12
Van Den, B.A.13
-
41
-
-
32244441965
-
The expression of fibroblast growth factors and their receptors in Hodgkin's lymphoma
-
DOI 10.1002/path.1900
-
Khnykin D, Troen G, Berner JM, et al: The expression of fibroblast growth factors and their receptors in Hodgkin's lymphoma. J Pathol 208:431-438, 2006 (Pubitemid 43210531)
-
(2006)
Journal of Pathology
, vol.208
, Issue.3
, pp. 431-438
-
-
Khnykin, D.1
Troen, G.2
Berner, J.-M.3
Delabie, J.4
-
42
-
-
11144354408
-
Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin's lymphoma or Hodgkin's lymphoma
-
DOI 10.1016/j.leukres.2003.11.002, PII S0145212603003916
-
Giles FJ, Vose JM, Do KA, et al: Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin's lymphoma or Hodgkin's lymphoma. Leuk Res 28:595-604, 2004 (Pubitemid 38543196)
-
(2004)
Leukemia Research
, vol.28
, Issue.6
, pp. 595-604
-
-
Giles, F.J.1
Vose, J.M.2
Do, K.-A.3
Johnson, M.M.4
Manshouri, T.5
Bociek, G.6
Bierman, P.J.7
O'Brien, S.M.8
Kantarjian, H.M.9
Armitage, J.O.10
Albitar, M.11
-
43
-
-
0025737623
-
Expression of macrophage colony-stimulating factor (M-CSF) in two Hodgkin's Reed-Sternberg (H-RS) cell lines, HDLM-1 and KM-H2, and in H-RS cells in tissues
-
Hsu PL, Lin YC, Hsu SM: Expression of macrophage colony-stimulating factor (M-CSF) in two Hodgkin's Reed-Sternberg (H-RS) cell lines, HDLM-1 and KM-H2, and in H-RS cells in tissues. Int J Hematol 54:315-326, 1991
-
(1991)
Int J Hematol
, vol.54
, pp. 315-326
-
-
Hsu, P.L.1
Lin, Y.C.2
Hsu, S.M.3
-
44
-
-
77952190003
-
Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma
-
Lamprecht B, Walter K, Kreher S, et al: Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma. Nat Med 16:571-579, 2010
-
(2010)
Nat Med
, vol.16
, pp. 571-579
-
-
Lamprecht, B.1
Walter, K.2
Kreher, S.3
-
45
-
-
10344244536
-
Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line
-
Pinto A, Aldinucci D, Gloghini A, et al: Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line. Blood 88:3299-3305, 1996 (Pubitemid 26365562)
-
(1996)
Blood
, vol.88
, Issue.9
, pp. 3299-3305
-
-
Pinto, A.1
Aldinucci, D.2
Gloghini, A.3
Zagonel, V.4
Degan, M.5
Improta, S.6
Juzbasic, S.7
Todesco, M.8
Perin, V.9
Gattei, V.10
Herrmann, F.11
Gruss, H.-J.12
Carbone, A.13
-
46
-
-
0141634201
-
Expression of CCL5/RANTES by Hodgkin and Reed- Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue
-
Fischer M, Juremalm M, Olsson N, et al: Expression of CCL5/RANTES by Hodgkin and Reed- Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue. Int J Cancer 107:197-201, 2003
-
(2003)
Int J Cancer
, vol.107
, pp. 197-201
-
-
Fischer, M.1
Juremalm, M.2
Olsson, N.3
-
47
-
-
0035869293
-
CC chemokines and the receptors CCR3 and CCR5 are differentially expressed in the nonneoplastic leukocytic infiltrates of Hodgkin disease
-
DOI 10.1182/blood.V97.6.1543
-
Buri C, Korner M, Scharli P, et al: CC chemokines and the receptors CCR3 and CCR5 are differentially expressed in the nonneoplastic leukocytic infiltrates of Hodgkin disease. Blood 97:1543-1548, 2001 (Pubitemid 32217213)
-
(2001)
Blood
, vol.97
, Issue.6
, pp. 1543-1548
-
-
Buri, C.1
Korner, M.2
Scharli, P.3
Cefai, D.4
Uguccioni, M.5
Mueller, C.6
Laissue, J.A.7
Mazzucchelli, L.8
-
48
-
-
0033567914
-
Hodgkin/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils
-
Jundt F, Anagnostopoulos I, Bommert K, et al: Hodgkin/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils. Blood 94:2065-2071, 1999 (Pubitemid 29430423)
-
(1999)
Blood
, vol.94
, Issue.6
, pp. 2065-2071
-
-
Jundt, F.1
Anagnostopoulos, I.2
Bommert, K.3
Emmerich, F.4
Muller, G.5
Foss, H.-D.6
Royer, H.-D.7
Stein, H.8
Dorken, B.9
-
49
-
-
0033058533
-
High expression of the CC chemokine TARC in Reed- Sternberg cells: A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma
-
van den Berg A, Visser L, Poppema S: High expression of the CC chemokine TARC in Reed- Sternberg cells: A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma. Am J Pathol 154:1685-1691, 1999
-
(1999)
Am J Pathol
, vol.154
, pp. 1685-1691
-
-
Van Den Berg, A.1
Visser, L.2
Poppema, S.3
-
50
-
-
0036533604
-
Infiltration of Th1 and Th2 lymphocytes around Hodgkin and Reed-Sternberg (H&RS) cells in Hodgkin disease: Relation with expression of CXC and CC chemokines on H&RS cells
-
DOI 10.1002/ijc.10218
-
Ohshima K, Tutiya T, Yamaguchi T, et al: Infiltration of Th1 and Th2 lymphocytes around Hodgkin and Reed-Sternberg (H&RS) cells in Hodgkin disease: Relation with expression of CXC and CC chemokines on H&RS cells. Int J Cancer 98:567-572, 2002 (Pubitemid 34208558)
-
(2002)
International Journal of Cancer
, vol.98
, Issue.4
, pp. 567-572
-
-
Ohshima, K.1
Tutiya, T.2
Yamaguchi, T.3
Suzuki, K.4
Suzumiya, J.5
Kawasaki, C.6
Haraoka, S.7
Kikuchi, M.8
-
51
-
-
0034962511
-
TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma
-
DOI 10.1097/00000478-200107000-00011
-
Peh SC, Kim LH, Poppema S: TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma. Am J Surg Pathol 25:925-929, 2001 (Pubitemid 32594986)
-
(2001)
American Journal of Surgical Pathology
, vol.25
, Issue.7
, pp. 925-929
-
-
Peh, S.C.1
Kim, L.H.2
Poppema, S.3
-
52
-
-
0035215993
-
Macrophage-derived chemokine expression in classical Hodgkin's lymphoma: Application of tissue microarrays
-
DOI 10.1038/modpathol.3880473
-
Hedvat CV, Jaffe ES, Qin J, et al: Macrophage-derived chemokine expression in classical Hodgkin's lymphoma: Application of tissue microarrays. Mod Pathol 14:1270-1276, 2001 (Pubitemid 33151170)
-
(2001)
Modern Pathology
, vol.14
, Issue.12
, pp. 1270-1276
-
-
Hedvat, C.V.1
Jaffe, E.S.2
Qin, J.3
Filippa, D.A.4
Cordon-Cardo, C.5
Tosato, G.6
Nimer, S.D.7
Teruya-Feldstein, J.8
-
53
-
-
0029964093
-
Interleukin-8 in Hodgkin's disease: Preferential expression by reactive cells and association with neutrophil density
-
Foss HD, Herbst H, Gottstein S, et al: Interleukin-8 in Hodgkin's disease: Preferential expression by reactive cells and association with neutrophil density. Am J Pathol 148:1229-1236, 1996 (Pubitemid 26108258)
-
(1996)
American Journal of Pathology
, vol.148
, Issue.4
, pp. 1229-1236
-
-
Foss, H.-D.1
Herbst, H.2
Gottstein, S.3
Demel, G.4
Araujo, I.5
Stein, H.6
-
54
-
-
0031785452
-
The monocyte chemotactic protein 1 (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours
-
Luciani MG, Stoppacciaro A, Peri G, et al: The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours. Mol Pathol 51:273-276, 1998 (Pubitemid 28480345)
-
(1998)
Journal of Clinical Pathology - Molecular Pathology
, vol.51
, Issue.5
, pp. 273-276
-
-
Luciani, M.G.1
Stoppacciaro, A.2
Peri, G.3
Mantovani, A.4
Ruco, L.P.5
-
55
-
-
0028029111
-
Interleukin-7, interleukin-8, soluble TNF receptor, and p53 protein levels are elevated in the serum of patients with Hodgkin's disease
-
Trumper L, Jung W, Dahl G, et al: Interleukin-7, interleukin-8, soluble TNF receptor, and p53 protein levels are elevated in the serum of patients with Hodgkin's disease. Ann Oncol 5:93-96, 1994 (suppl 1) (Pubitemid 24051326)
-
(1994)
Annals of Oncology
, vol.5
, Issue.SUPPL. 1
, pp. 93-96
-
-
Trumper, L.1
Jung, W.2
Dahl, G.3
Diehl, V.4
Gause, A.5
Pfreundschuh, M.6
-
56
-
-
0029029088
-
Serum cytokine levels correlate with clinical parameters in Hodgkin's disease
-
Gorschlüter M, Bohlen H, Hasenclever D, et al: Serum cytokine levels correlate with clinical parameters in Hodgkin's disease. Ann Oncol 6:477-482, 1995
-
(1995)
Ann Oncol
, vol.6
, pp. 477-482
-
-
Gorschlüter, M.1
Bohlen, H.2
Hasenclever, D.3
-
57
-
-
0037082511
-
Up-regulation of the chemokine receptor CCR7 in classical but not in lymphocyte-predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs
-
DOI 10.1182/blood.V99.4.1109
-
Hopken UE, Foss HD, Meyer D, et al: Upregulation of the chemokine receptor CCR7 in classical but not in lymphocyte-predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs. Blood 99:1109-1116, 2002 (Pubitemid 34547061)
-
(2002)
Blood
, vol.99
, Issue.4
, pp. 1109-1116
-
-
Hopken, U.E.1
Foss, H.-D.2
Meyer, D.3
Hinz, M.4
Leder, K.5
Stein, H.6
Lipp, M.7
-
58
-
-
0020074168
-
In situ immunologic characterization of cellular constituents in lymph nodes and spleens involved by Hodgkin's disease
-
Poppema S, Bhan AK, Reinherz EL, et al: In situ immunologic characterization of cellular constituents in lymph nodes and spleens involved by Hodgkin's disease. Blood 59:226-232, 1982
-
(1982)
Blood
, vol.59
, pp. 226-232
-
-
Poppema, S.1
Bhan, A.K.2
Reinherz, E.L.3
-
59
-
-
0030067451
-
CD45 (leucocyte common antigen) expression in T and B lymphocyte subsets
-
Poppema S, Lai R, Visser L, et al: CD45 (leucocyte common antigen) expression in T and B lymphocyte subsets. Leuk Lymphoma 20:217-222, 1996
-
(1996)
Leuk Lymphoma
, vol.20
, pp. 217-222
-
-
Poppema, S.1
Lai, R.2
Visser, L.3
-
60
-
-
0031803784
-
Cytokines in hematopoiesis
-
Alexander WS: Cytokines in hematopoiesis. Int Rev Immunol 16:651-682, 1998
-
(1998)
Int Rev Immunol
, vol.16
, pp. 651-682
-
-
Alexander, W.S.1
-
61
-
-
58149398634
-
CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis
-
Truman LA, Ford CA, Pasikowska M, et al: CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis. Blood 112:5026-5036, 2008
-
(2008)
Blood
, vol.112
, pp. 5026-5036
-
-
Truman, L.A.1
Ford, C.A.2
Pasikowska, M.3
-
62
-
-
77950950894
-
Macrophage diversity enhances tumor progression and metastasis
-
Qian BZ, Pollard JW: Macrophage diversity enhances tumor progression and metastasis. Cell 141:39-51, 2010
-
(2010)
Cell
, vol.141
, pp. 39-51
-
-
Qian, B.Z.1
Pollard, J.W.2
-
63
-
-
5144224056
-
Antiproliferative activity of a humanized anti-CD74 monoclonal antibody, hLL1, on B-cell malignancies
-
DOI 10.1182/blood-2004-03-0890
-
Stein R, Qu Z, Cardillo TM, et al: Antiproliferative activity of a humanized anti-CD74 monoclonal antibody, hLL1, on B-cell malignancies. Blood 104:3705-3711, 2004 (Pubitemid 39564448)
-
(2004)
Blood
, vol.104
, Issue.12
, pp. 3705-3711
-
-
Stein, R.1
Qu, Z.2
Cardillo, T.M.3
Chen, S.4
Rosario, A.5
Horak, I.D.6
Hansen, H.J.7
Goldenberg, D.M.8
-
64
-
-
12444285441
-
MIF signal transduction initiated by binding to CD74
-
DOI 10.1084/jem.20030286
-
Leng L, Metz CN, Fang Y, et al: MIF signal transduction initiated by binding to CD74. J Exp Med 197:1467-1476, 2003 (Pubitemid 36686708)
-
(2003)
Journal of Experimental Medicine
, vol.197
, Issue.11
, pp. 1467-1476
-
-
Leng, L.1
Metz, C.N.2
Fang, Y.3
Xu, J.4
Donnelly, S.5
Baugh, J.6
Delohery, T.7
Chen, Y.8
Mitchell, R.A.9
Bucala, R.10
-
65
-
-
0035570881
-
Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: Possible autocrine mechanism and involvement in fibrosis
-
DOI 10.1046/j.1365-2559.2001.01083.x
-
Ohshima K, Akaiwa M, Umeshita R, et al: Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: Possible autocrine mechanism and involvement in fibrosis. Histopathology 38:368-375, 2001 (Pubitemid 34225031)
-
(2001)
Histopathology
, vol.38
, Issue.4
, pp. 368-375
-
-
Ohshima, K.1
Akaiwa, M.2
Umeshita, R.3
Suzumiya, J.4
Izuhara, K.5
Kikuchi, M.6
-
66
-
-
42149168527
-
ICOS, CD40, and lymphotoxin beta receptors signal sequentially and interdependently to initiate a germinal center reaction
-
Vu F, Dianzani U, Ware CF, et al: ICOS, CD40, and lymphotoxin beta receptors signal sequentially and interdependently to initiate a germinal center reaction. J Immunol 180:2284-2293, 2008
-
(2008)
J Immunol
, vol.180
, pp. 2284-2293
-
-
Vu, F.1
Dianzani, U.2
Ware, C.F.3
-
67
-
-
49249095467
-
PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma
-
Nam-Cha SH, Roncador G, Sanchez-Verde L, et al: PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma. Am J Surg Pathol 32:1252-1257, 2008
-
(2008)
Am J Surg Pathol
, vol.32
, pp. 1252-1257
-
-
Nam-Cha, S.H.1
Roncador, G.2
Sanchez-Verde, L.3
-
68
-
-
57749171165
-
The biology of Hodgkin's lymphoma
-
Küppers R: The biology of Hodgkin's lymphoma. Nat Rev Cancer 9:15-27, 2009
-
(2009)
Nat Rev Cancer
, vol.9
, pp. 15-27
-
-
Küppers, R.1
-
69
-
-
0037082477
-
Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2
-
DOI 10.1182/blood.V99.4.1381
-
Joos S, Menz CK, Wrobel G, et al: Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. Blood 99:1381-1387, 2002 (Pubitemid 34547095)
-
(2002)
Blood
, vol.99
, Issue.4
, pp. 1381-1387
-
-
Joos, S.1
Menz, C.K.2
Wrobel, G.3
Siebert, R.4
Gesk, S.5
Ohl, S.6
Mechtersheimer, G.7
Trumper, L.8
Moller, P.9
Lichter, P.10
Barth, T.F.E.11
-
70
-
-
0037082493
-
Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma
-
DOI 10.1182/blood.V99.4.1474
-
Martín-Subero JI, Gesk S, Harder L, et al: Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. Blood 99:1474-1477, 2002 (Pubitemid 34547107)
-
(2002)
Blood
, vol.99
, Issue.4
, pp. 1474-1477
-
-
Martin-Subero, J.I.1
Gesk, S.2
Harder, L.3
Sonoki, T.4
Tucker, P.W.5
Schlegelberger, B.6
Grote, W.7
Novo, F.J.8
Calasanz, M.J.9
Hansmann, M.L.10
Dyer, M.J.S.11
Siebert, R.12
-
71
-
-
0042835509
-
Classical Hodgkin lymphoma is associated with frequent gains of 17q
-
DOI 10.1002/gcc.10266
-
Chui DT, Hammond D, Baird M, et al: Classical Hodgkin lymphoma is associated with frequent gains of 17q. Genes Chromosomes Cancer 38:126-136, 2003 (Pubitemid 37093430)
-
(2003)
Genes Chromosomes and Cancer
, vol.38
, Issue.2
, pp. 126-136
-
-
Chui, D.T.Y.1
Hammond, D.2
Baird, M.3
Shield, L.4
Jackson, R.5
Jarrett, R.F.6
-
72
-
-
77955866440
-
Genomewide copy number analysis of Hodgkin Reed- Sternberg cells identifies recurrent imbalances with correlations to treatment outcome
-
Steidl C, Telenius A, Shah SP, et al: Genomewide copy number analysis of Hodgkin Reed- Sternberg cells identifies recurrent imbalances with correlations to treatment outcome. Blood 116:418-427, 2010
-
(2010)
Blood
, vol.116
, pp. 418-427
-
-
Steidl, C.1
Telenius, A.2
Shah, S.P.3
-
73
-
-
28844472948
-
Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas
-
DOI 10.1182/blood-2004-09-3620
-
Mathas S, Jöhrens K, Joos S, et al: Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas. Blood 106:4287-4293, 2005 (Pubitemid 41775938)
-
(2005)
Blood
, vol.106
, Issue.13
, pp. 4287-4293
-
-
Mathas, S.1
Johrens, K.2
Joos, S.3
Lietz, A.4
Hummel, F.5
Janz, M.6
Jundt, F.7
Anagnostopoulos, I.8
Bommert, K.9
Lichter, P.10
Stein, H.11
Scheidereit, C.12
Dorken, B.13
-
74
-
-
33745619800
-
Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma
-
author reply 402-403
-
Martin-Subero JI, Wlodarska I, Bastard C, et al: Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma. Blood 108:401-402, 2006; author reply 402-403
-
(2006)
Blood
, vol.108
, pp. 401-402
-
-
Martin-Subero, J.I.1
Wlodarska, I.2
Bastard, C.3
-
75
-
-
0033587084
-
Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha
-
DOI 10.1038/sj.onc.1202893
-
Cabannes E, Khan G, Aillet F, et al: Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha. Oncogene 18:3063-3070, 1999 (Pubitemid 29261226)
-
(1999)
Oncogene
, vol.18
, Issue.20
, pp. 3063-3070
-
-
Cabannes, E.1
Khan, G.2
Aillet, F.3
Jarrett, R.F.4
Hay, R.T.5
-
76
-
-
0033230955
-
Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells
-
Emmerich F, Meiser M, Hummel M, et al: Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells. Blood 94:3129-3134, 1999 (Pubitemid 29512720)
-
(1999)
Blood
, vol.94
, Issue.9
, pp. 3129-3134
-
-
Emmerich, F.1
Meiser, M.2
Hummel, M.3
Demel, G.4
Foss, H.-D.5
Jundt, F.6
Mathas, S.7
Krappmann, D.8
Scheidereit, C.9
Stein, H.10
Dorken, B.11
-
77
-
-
0034677104
-
Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma
-
Jungnickel B, Staratschek-Jox A, Bräuninger A, et al: Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma. J Exp Med 191:395-402, 2000
-
(2000)
J Exp Med
, vol.191
, pp. 395-402
-
-
Jungnickel, B.1
Staratschek-Jox, A.2
Bräuninger, A.3
-
78
-
-
0242391871
-
Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells
-
DOI 10.1002/path.1454
-
Emmerich F, Theurich S, Hummel M, et al: Inactivating I kappa B epsilon mutations in Hodgkin/ Reed-Sternberg cells. J Pathol 201:413-420, 2003 (Pubitemid 37408262)
-
(2003)
Journal of Pathology
, vol.201
, Issue.3
, pp. 413-420
-
-
Emmerich, F.1
Theurich, S.2
Hummel, M.3
Haeffker, A.4
Vry, M.S.5
Dohner, K.6
Bommert, K.7
Stein, H.8
Dorken, B.9
-
79
-
-
66049124247
-
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
-
Schmitz R, Hansmann ML, Bohle V, et al: TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J Exp Med 206:981-989, 2009
-
(2009)
J Exp Med
, vol.206
, pp. 981-989
-
-
Schmitz, R.1
Hansmann, M.L.2
Bohle, V.3
-
80
-
-
33646382121
-
Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation
-
Weniger MA, Melzner I, Menz CK, et al: Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation. Oncogene 25:2679-2684, 2006
-
(2006)
Oncogene
, vol.25
, pp. 2679-2684
-
-
Weniger, M.A.1
Melzner, I.2
Menz, C.K.3
-
81
-
-
36148989576
-
Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6
-
DOI 10.1182/blood-2007-03-082511
-
Mottok A, Renné C, Willenbrock K, et al: Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6. Blood 110:3387-3390, 2007 (Pubitemid 350106334)
-
(2007)
Blood
, vol.110
, Issue.9
, pp. 3387-3390
-
-
Mottok, A.1
Renne, C.2
Willenbrock, K.3
Hansmann, M.-L.4
Brauninger, A.5
-
82
-
-
0035479946
-
TP53 gene mutations in Hodgkin lymphoma are infrequent and not associated with absence of Epstein-Barr virus
-
DOI 10.1002/ijc.1438
-
Maggio EM, Stekelenburg E, Van den Berg A, et al: TP53 gene mutations in Hodgkin lymphoma are infrequent and not associated with absence of Epstein-Barr virus. Int J Cancer 94:60-66, 2001 (Pubitemid 32801753)
-
(2001)
International Journal of Cancer
, vol.94
, Issue.1
, pp. 60-66
-
-
Maggio, E.M.1
Stekelenburg, E.2
Van Berg, A.D.3
Poppema, S.4
-
83
-
-
0035315880
-
Role of Jak kinases and STATs in cytokine signal transduction
-
Leonard WJ: Role of Jak kinases and STATs in cytokine signal transduction. Int J Hematol 73:271-277, 2001
-
(2001)
Int J Hematol
, vol.73
, pp. 271-277
-
-
Leonard, W.J.1
-
84
-
-
61849157254
-
TNFR signaling: Ubiquitin-conjugated TRAFfic signals control stop-and- Go for MAPK signaling complexes
-
Karin M, Gallagher E: TNFR signaling: Ubiquitin-conjugated TRAFfic signals control stop-and- go for MAPK signaling complexes. Immunol Rev 228:225-240, 2009
-
(2009)
Immunol Rev
, vol.228
, pp. 225-240
-
-
Karin, M.1
Gallagher, E.2
-
85
-
-
0037032835
-
The protein kinase complement of the human genome
-
Manning G, Whyte DB, Martinez R, et al: The protein kinase complement of the human genome. Science 298:1912-1934, 2002
-
(2002)
Science
, vol.298
, pp. 1912-1934
-
-
Manning, G.1
Whyte, D.B.2
Martinez, R.3
-
86
-
-
0028857781
-
CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease
-
Carbone A, Gloghini A, Gruss HJ, et al: CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease. Am J Pathol 147:912-922, 1995
-
(1995)
Am J Pathol
, vol.147
, pp. 912-922
-
-
Carbone, A.1
Gloghini, A.2
Gruss, H.J.3
-
87
-
-
0032055536
-
Gene expression by single Reed-Sternberg cells: Pathways of apoptosis and activation
-
Messineo C, Jamerson MH, Hunter E, et al: Gene expression by single Reed-Sternberg cells: Pathways of apoptosis and activation. Blood 91:2443-2451, 1998 (Pubitemid 28155519)
-
(1998)
Blood
, vol.91
, Issue.7
, pp. 2443-2451
-
-
Messineo, C.1
Jamerson, M.H.2
Hunter, E.3
Braziel, R.4
Bagg, A.5
Irving, S.G.6
Cossman, J.7
-
88
-
-
0032536860
-
Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor
-
DOI 10.1093/emboj/17.6.1700
-
Kilger E, Kieser A, Baumann M, et al: Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. Embo J 17:1700-1709, 1998 (Pubitemid 28119123)
-
(1998)
EMBO Journal
, vol.17
, Issue.6
, pp. 1700-1709
-
-
Kilger, E.1
Kieser, A.2
Baumann, M.3
Hammerschmidt, W.4
-
89
-
-
34249709065
-
Paracrine promotion of tumor development by the TNF ligand APRIL in Hodgkin's Disease [11]
-
DOI 10.1038/sj.leu.2404627, PII 2404627
-
Schwaller J, Went P, Matthes T, et al: Paracrine promotion of tumor development by the TNF ligand APRIL in Hodgkin's disease. Leukemia 21:1324-1327, 2007 (Pubitemid 46831829)
-
(2007)
Leukemia
, vol.21
, Issue.6
, pp. 1324-1327
-
-
Schwaller, J.1
Went, P.2
Matthes, T.3
Dirnhofer, S.4
Donze, O.5
Mhawech-Fauceglia, P.6
Myit, S.7
Huard, B.8
-
90
-
-
0037079728
-
Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Stenberg cells of Hodgkin lymphoma
-
DOI 10.1182/blood.V99.2.618
-
Skinnider BF, Elia AJ, Gascoyne RD, et al: Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 99:618-626, 2002 (Pubitemid 34533100)
-
(2002)
Blood
, vol.99
, Issue.2
, pp. 618-626
-
-
Skinnider, B.F.1
Elia, A.J.2
Gascoyne, R.D.3
Patterson, B.4
Trumper, L.5
Kapp, U.6
Mak, T.W.7
-
91
-
-
47149098995
-
IL-21 is expressed in Hodgkin lymphoma and activates STAT5: Evidence that activated STAT5 is required for Hodgkin lymphomagenesis
-
Scheeren FA, Diehl SA, Smit LA, et al: IL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis. Blood 111:4706-4715, 2008
-
(2008)
Blood
, vol.111
, pp. 4706-4715
-
-
Scheeren, F.A.1
Diehl, S.A.2
Smit, L.A.3
-
92
-
-
0035437158
-
STAT3 is constitutively activated in Hodgkin cell lines
-
Kube D, Holtick U, Vockerodt M, et al: STAT3 is constitutively activated in Hodgkin cell lines. Blood 98:762-770, 2001
-
(2001)
Blood
, vol.98
, pp. 762-770
-
-
Kube, D.1
Holtick, U.2
Vockerodt, M.3
-
93
-
-
77953534075
-
The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape
-
Aldinucci D, Gloghini A, Pinto A, et al: The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape. J Pathol 221:248-263, 2010
-
(2010)
J Pathol
, vol.221
, pp. 248-263
-
-
Aldinucci, D.1
Gloghini, A.2
Pinto, A.3
-
94
-
-
0027772924
-
Expression of interleukin-2Ralpha and interleukin-2Rbeta in Hodgkin's disease
-
Tesch H, Gunther A, Abts H, et al: Expression of interleukin-2R alpha and interleukin-2R beta in Hodgkin's disease. Am J Pathol 142:1714-1720, 1993 (Pubitemid 24057065)
-
(1993)
American Journal of Pathology
, vol.142
, Issue.6
, pp. 1714-1720
-
-
Tesch, H.1
Gunther, A.2
Abts, H.3
Jucker, M.4
Klein, S.5
Krueger, G.R.F.6
Diehl, V.7
-
95
-
-
0027178303
-
Single-cell analysis of Hodgkin and Reed-Sternberg cells: Molecular heterogeneity of gene expression and p53 mutations
-
Trumper LH, Brady G, Bagg A, et al: Single-cell analysis of Hodgkin and Reed-Sternberg cells: Molecular heterogeneity of gene expression and p53 mutations. Blood 81:3097-3115, 1993 (Pubitemid 23162131)
-
(1993)
Blood
, vol.81
, Issue.11
, pp. 3097-3115
-
-
Trumper, L.H.1
Brady, G.2
Bagg, A.3
Gray, D.4
Loke, S.L.5
Griesser, H.6
Wagman, R.7
Braziel, R.8
Gascoyne, R.D.9
Vicini, S.10
Iscove, N.N.11
Cossman, J.12
Mak, T.W.13
-
96
-
-
0025867022
-
Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease
-
Jucker M, Abts H, Li W, et al: Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease. Blood 77:2413-2418, 1991
-
(1991)
Blood
, vol.77
, pp. 2413-2418
-
-
Jucker, M.1
Abts, H.2
Li, W.3
-
97
-
-
67650087810
-
Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma
-
Cattaruzza L, Gloghini A, Olivo K, et al: Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma. Int J Cancer 125:1092-1101, 2009
-
(2009)
Int J Cancer
, vol.125
, pp. 1092-1101
-
-
Cattaruzza, L.1
Gloghini, A.2
Olivo, K.3
-
98
-
-
0032171594
-
Expression of hepatocyte growth factor and its receptor c-met in human leukemia-lymphoma cell lines
-
DOI 10.1016/S0145-2126(98)00071-X, PII S014521269800071X
-
Pons E, Uphoff CC, Drexler HG: Expression of hepatocyte growth factor and its receptor c-met in human leukemia-lymphoma cell lines. Leuk Res 22:797-804, 1998 (Pubitemid 28388957)
-
(1998)
Leukemia Research
, vol.22
, Issue.9
, pp. 797-804
-
-
Pons, E.1
Uphoff, C.C.2
Drexler, H.G.3
-
99
-
-
0035865510
-
Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease
-
DOI 10.1182/blood.V97.4.1063
-
Teofili L, Di Febo AL, Pierconti F, et al: Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease. Blood 97:1063-1069, 2001 (Pubitemid 32154294)
-
(2001)
Blood
, vol.97
, Issue.4
, pp. 1063-1069
-
-
Teofili, L.1
Di, F.A.L.2
Pierconti, F.3
Maggiano, N.4
Bendandi, M.5
Rutella, S.6
Cingolani, A.7
Di, R.N.8
Musto, P.9
Pileri, S.10
Leone, G.11
Larocca, L.M.12
-
100
-
-
18544380247
-
Autocrine- And paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma
-
DOI 10.1182/blood-2004-10-4008
-
Renné C, Willenbrock K, Küppers R, et al: Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma. Blood 105: 4051-4059, 2005 (Pubitemid 40656155)
-
(2005)
Blood
, vol.105
, Issue.10
, pp. 4051-4059
-
-
Renne, C.1
Willenbrock, K.2
Kuppers, R.3
Hansmann, M.-L.4
Brauninger, A.5
-
101
-
-
33744469340
-
Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma
-
Willenbrock K, Küppers R, Renné C, et al: Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma. Haematologica 91:596-604, 2006 (Pubitemid 43799453)
-
(2006)
Haematologica
, vol.91
, Issue.5
, pp. 596-604
-
-
Willenbrock, K.1
Kuppers, R.2
Renne, C.3
Brune, V.4
Eckerle, S.5
Weidmann, E.6
Brauninger, A.7
Hansmann, M.-L.8
-
102
-
-
36049049415
-
Autocrine NGFbeta/TRKA signalling is an important survival factor for Hodgkin lymphoma derived cell lines
-
DOI 10.1016/j.leukres.2007.05.019, PII S014521260700224X
-
Renné C, Minner S, Küppers R, et al: Autocrine NGFbeta/TRKA signalling is an important survival factor for Hodgkin lymphoma derived cell lines. Leuk Res 32:163-167, 2008 (Pubitemid 350100851)
-
(2008)
Leukemia Research
, vol.32
, Issue.1
, pp. 163-167
-
-
Renne, C.1
Minner, S.2
Kuppers, R.3
Hansmann, M.-L.4
Brauninger, A.5
-
105
-
-
1442283424
-
Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma
-
DOI 10.1182/blood-2003-07-2594
-
Marshall NA, Christie LE, Munro LR, et al: Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood 103:1755-1762, 2004 (Pubitemid 38268969)
-
(2004)
Blood
, vol.103
, Issue.5
, pp. 1755-1762
-
-
Marshall, N.A.1
Christie, L.E.2
Munro, L.R.3
Culligan, D.J.4
Johnston, P.W.5
Barker, R.N.6
Vickers, M.A.7
-
106
-
-
33749127585
-
+ T-cell function in Hodgkin lymphoma patients
-
DOI 10.1182/blood-2006-04-015164
-
Gandhi MK, Lambley E, Duraiswamy J, et al: Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients. Blood 108:2280-2289, 2006 (Pubitemid 44497511)
-
(2006)
Blood
, vol.108
, Issue.7
, pp. 2280-2289
-
-
Gandhi, M.K.1
Lambley, E.2
Duraiswamy, J.3
Dua, U.4
Smith, C.5
Elliott, S.6
Gill, D.7
Marlton, P.8
Seymour, J.9
Khanna, R.10
-
107
-
-
38349059732
-
Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: Involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions
-
Aldinucci D, Lorenzon D, Cattaruzza L, et al: Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: Involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions. Int J Cancer 122:769-776, 2008
-
(2008)
Int J Cancer
, vol.122
, pp. 769-776
-
-
Aldinucci, D.1
Lorenzon, D.2
Cattaruzza, L.3
-
108
-
-
34548395936
-
+ naive T cells
-
DOI 10.1189/jlb.0906565
-
Tanijiri T, Shimizu T, Uehira K, et al: Hodgkin's Reed-Sternberg cell line (KM-H2) promotes a bidirectional differentiation of CD4+CD25+Foxp3+ T cells and CD4+ cytotoxic T lymphocytes from CD4+ naive T cells. J Leukoc Biol 82:576-584, 2007 (Pubitemid 47367148)
-
(2007)
Journal of Leukocyte Biology
, vol.82
, Issue.3
, pp. 576-584
-
-
Tanijiri, T.1
Shimizu, T.2
Uehira, K.3
Yokoi, T.4
Amuro, H.5
Sugimoto, H.6
Torii, Y.7
Tajima, K.8
Ito, T.9
Amakawa, R.10
Fukuhara, S.11
-
109
-
-
0025297289
-
Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease
-
Kadin ME, Agnarsson BA, Ellingsworth LR, et al: Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease. Am J Pathol 136:1209-1214, 1990 (Pubitemid 20210318)
-
(1990)
American Journal of Pathology
, vol.136
, Issue.6
, pp. 1209-1214
-
-
Kadin, M.E.1
Agnarsson, B.A.2
Ellingsworth, L.R.3
Newcom, S.R.4
-
110
-
-
0020646873
-
2 secretion in Hodgkin's disease and its relation to decreased cellular immunity
-
Passwell J, Levanon M, Davidsohn J, et al: Monocyte PGE2 secretion in Hodgkin's disease and its relation to decreased cellular immunity. Clin Exp Immunol 51:61-68, 1983 (Pubitemid 13168161)
-
(1983)
Clinical and Experimental Immunology
, vol.51
, Issue.1
, pp. 61-68
-
-
Passwell, J.1
Levanon, M.2
Davidsohn, J.3
Ramot, B.4
-
111
-
-
0027724464
-
2 levels found in 14 patients undergoing autologous bone marrow or stem cell transplantation
-
Cayeux SJ, Beverley PC, Schulz R, et al: Elevated plasma prostaglandin E2 levels found in 14 patients undergoing autologous bone marrow or stem cell transplantation. Bone Marrow Transplant 12:603-608, 1993 (Pubitemid 24020993)
-
(1993)
Bone Marrow Transplantation
, vol.12
, Issue.6
, pp. 603-608
-
-
Cayeux, S.J.1
Beverley, P.C.L.2
Schulz, R.3
Dorken, B.4
-
112
-
-
0036499224
-
Prostaglandins as modulators of immunity
-
DOI 10.1016/S1471-4906(01)02154-8, PII S1471490601021548
-
Harris SG, Padilla J, Koumas L, et al: Prostaglandins as modulators of immunity. Trends Immunol 23:144-150, 2002 (Pubitemid 34178297)
-
(2002)
Trends in Immunology
, vol.23
, Issue.3
, pp. 144-150
-
-
Harris, S.G.1
Padilla, J.2
Koumas, L.3
Ray, D.4
Phipps, R.P.5
-
113
-
-
31544464331
-
+ T cell activation by inhibition of lck: Implications in Hodgkin's lymphoma
-
DOI 10.1158/0008-5472.CAN-05-3252
-
Chemnitz JM, Driesen J, Classen S, et al: Prostaglandin E2 impairs CD4+ T cell activation by inhibition of lck: Implications in Hodgkin's lymphoma. Cancer Res 66:1114-1122, 2006 (Pubitemid 43165980)
-
(2006)
Cancer Research
, vol.66
, Issue.2
, pp. 1114-1122
-
-
Chemnitz, J.M.1
Driesen, J.2
Classen, S.3
Riley, J.L.4
Debey, S.5
Beyer, M.6
Popov, A.7
Zander, T.8
Schultze, J.L.9
-
114
-
-
0142147190
-
The role of CD30, CD40 and CD95 in the regulation of proliferation and apoptosis in classical Hodgkin's lymphoma
-
Kim LH, Eow GI, Peh SC, et al: The role of CD30, CD40 and CD95 in the regulation of proliferation and apoptosis in classical Hodgkin's lymphoma. Pathology 35:428-435, 2003
-
(2003)
Pathology
, vol.35
, pp. 428-435
-
-
Kim, L.H.1
Eow, G.I.2
Peh, S.C.3
-
115
-
-
0031570098
-
Role of Fas ligand (CD95L) in immune escape: The tumor cell strikes back
-
Walker PR, Saas P, Dietrich PY: Role of Fas ligand (CD95L) in immune escape: The tumor cell strikes back. J Immunol 158:4521-4524, 1997
-
(1997)
J Immunol
, vol.158
, pp. 4521-4524
-
-
Walker, P.R.1
Saas, P.2
Dietrich, P.Y.3
-
116
-
-
0035117646
-
Fas ligand expression in Hodgkin lymphoma
-
DOI 10.1097/00000478-200103000-00014
-
Verbeke CS, Wenthe U, Grobholz R, et al: Fas ligand expression in Hodgkin lymphoma. Am J Surg Pathol 25:388-394, 2001 (Pubitemid 32174208)
-
(2001)
American Journal of Surgical Pathology
, vol.25
, Issue.3
, pp. 388-394
-
-
Verbeke, C.S.1
Wenthe, U.2
Grobholz, R.3
Zentgraf, H.4
-
117
-
-
20444425695
-
Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis
-
DOI 10.1182/blood-2004-08-3337
-
Dotti G, Savoldo B, Pule M, et al: Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis. Blood 105:4677-4684, 2005 (Pubitemid 40807289)
-
(2005)
Blood
, vol.105
, Issue.12
, pp. 4677-4684
-
-
Dotti, G.1
Savoldo, B.2
Pule, M.3
Straathof, K.C.4
Biagi, E.5
Yvon, E.6
Vigouroux, S.7
Brenner, M.K.8
Rooney, C.M.9
-
118
-
-
34548033053
-
Galectin-1 mediated suppression of Epstein-Barr virus-specific T-cell immunity in classic Hodgkin lymphoma
-
DOI 10.1182/blood-2007-01-066100
-
Gandhi MK, Moll G, Smith C, et al: Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma. Blood 110:1326-1329, 2007 (Pubitemid 47281432)
-
(2007)
Blood
, vol.110
, Issue.4
, pp. 1326-1329
-
-
Gandhi, M.K.1
Moll, G.2
Smith, C.3
Dua, U.4
Lambley, E.5
Ramuz, O.6
Gill, D.7
Marlton, P.8
Seymour, J.F.9
Khanna, R.10
-
119
-
-
34548740090
-
The AP1-dependent secretion of galectin-1 by Reed-Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
-
DOI 10.1073/pnas.0706017104
-
Juszczynski P, Ouyang J, Monti S, et al: The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma. Proc Natl Acad Sci U S A 104:13134-13139, 2007 (Pubitemid 351737605)
-
(2007)
Proceedings of the National Academy of Sciences of the United States of America
, vol.104
, Issue.32
, pp. 13134-13139
-
-
Juszczynski, P.1
Ouyang, J.2
Monti, S.3
Rodig, S.J.4
Takeyama, K.5
Abramson, J.6
Chen, W.7
Kutok, J.L.8
Rabinovich, G.A.9
Shipp, M.A.10
-
120
-
-
42449147063
-
PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma
-
Yamamoto R, Nishikori M, Kitawaki T, et al: PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma. Blood 111:3220-3224, 2008
-
(2008)
Blood
, vol.111
, pp. 3220-3224
-
-
Yamamoto, R.1
Nishikori, M.2
Kitawaki, T.3
-
121
-
-
78049370405
-
Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
-
Green MR, Monti S, Rodig SJ, et al: Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Blood 116: 3268-3277, 2010
-
(2010)
Blood
, vol.116
, pp. 3268-3277
-
-
Green, M.R.1
Monti, S.2
Rodig, S.J.3
-
122
-
-
42649125225
-
PD-1 and its ligands in tolerance and immunity
-
DOI 10.1146/annurev.immunol.26.021607.090331
-
Keir ME, Butte MJ, Freeman GJ, et al: PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 26:677-704, 2008 (Pubitemid 351600389)
-
(2008)
Annual Review of Immunology
, vol.26
, pp. 677-704
-
-
Keir, M.E.1
Butte, M.J.2
Freeman, G.J.3
Sharpe, A.H.4
-
123
-
-
34547652282
-
HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma
-
DOI 10.1200/JCO.2006.10.0917
-
Diepstra A, van Imhoff GW, Karim-Kos HE, et al: HLA class II expression by Hodgkin Reed- Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma. J Clin Oncol 25: 3101-3108, 2007 (Pubitemid 47218058)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.21
, pp. 3101-3108
-
-
Diepstra, A.1
Van Imhoff, G.W.2
Karim-Kos, H.E.3
Van Den, B.A.4
Te, M.G.J.5
Niens, M.6
Nolte, I.M.7
Bastiaannet, E.8
Schaapveld, M.9
Vellenga, E.10
Poppema, S.11
-
124
-
-
77956546059
-
Expression of HLA class I and HLA class II by tumor cells in Chinese classical Hodgkin lymphoma patients
-
Huang X, van den Berg A, Gao Z, et al: Expression of HLA class I and HLA class II by tumor cells in Chinese classical Hodgkin lymphoma patients. PLoS One 5:e10865, 2010
-
(2010)
PLoS One
, vol.5
-
-
Huang, X.1
Van Den Berg, A.2
Gao, Z.3
-
125
-
-
33646229918
-
Immunobiology and pathophysiology of Hodgkin lymphomas
-
Poppema S: Immunobiology and pathophysiology of Hodgkin lymphomas. Hematology Am Soc Hematol Educ Program 231-238, 2005
-
(2005)
Hematology Am Soc Hematol Educ Program
, pp. 231-238
-
-
Poppema, S.1
-
126
-
-
33947503691
-
Global correlation of genome and transcriptome changes in classical Hodgkin lymphoma
-
DOI 10.1002/hon.804
-
Kluiver J, Kok K, Pfeil I, et al: Global correlation of genome and transcriptome changes in classical Hodgkin lymphoma. Hematol Oncol 25:21-29, 2007 (Pubitemid 46474311)
-
(2007)
Hematological Oncology
, vol.25
, Issue.1
, pp. 21-29
-
-
Kluiver, J.1
Kok, K.2
Pfeil, I.3
De Jong, D.4
Blokzijl, T.5
Harms, G.6
Van Der, V.P.7
Diepstra, A.8
Atayar, C.9
Poppema, S.10
Kuppers, R.11
Van Den, B.A.12
-
127
-
-
20744454814
-
Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma
-
DOI 10.1016/S0140-6736(05)66780-3, PII S0140673605667803
-
Diepstra A, Niens M, Vellenga E, et al: Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus- negative Hodgkin's lymphoma. Lancet 365:2216-2224, 2005 (Pubitemid 40853915)
-
(2005)
Lancet
, vol.365
, Issue.9478
, pp. 2216-2224
-
-
Diepstra, A.1
Niens, M.2
Vellenga, E.3
Van Imhoff, G.W.4
Nolte, I.M.5
Schaapveld, M.6
Van Der, S.G.7
Van Den, B.A.8
Kibbelaar, R.E.9
Te, M.G.J.10
Poppema, S.11
-
128
-
-
77950902491
-
HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma
-
Hjalgrim H, Rostgaard K, Johnson PC, et al: HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma. Proc Natl Acad Sci U S A 107:6400-6405, 2010
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 6400-6405
-
-
Hjalgrim, H.1
Rostgaard, K.2
Johnson, P.C.3
-
129
-
-
34948886255
-
+ Hodgkin lymphoma
-
DOI 10.1182/blood-2007-05-086934
-
Niens M, Jarrett RF, Hepkema B, et al: HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma. Blood 110:3310-3315, 2007 (Pubitemid 350106324)
-
(2007)
Blood
, vol.110
, Issue.9
, pp. 3310-3315
-
-
Niens, M.1
Jarrett, R.F.2
Hepkema, B.3
Nolte, I.M.4
Diepstra, A.5
Platteel, M.6
Kouprie, N.7
Delury, C.P.8
Gallagher, A.9
Visser, L.10
Poppema, S.11
Te, M.G.J.12
Van Den, B.A.13
-
130
-
-
38849095307
-
HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma
-
DOI 10.1111/j.1399-0039.2008.01005.x
-
Diepstra A, Poppema S, Boot M, et al: HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma. Tissue Antigens 71:219-226, 2008 (Pubitemid 351197075)
-
(2008)
Tissue Antigens
, vol.71
, Issue.3
, pp. 219-226
-
-
Diepstra, A.1
Poppema, S.2
Boot, M.3
Visser, L.4
Nolte, I.M.5
Niens, M.6
Te, M.G.J.7
Van Den, B.A.8
-
131
-
-
63149134916
-
A TaqMan low-density array to predict outcome in advanced Hodgkin's lymphoma using paraffin-embedded samples
-
Sánchez-Espiridión B, Sánchez-Aguilera A, Montalbán C, et al: A TaqMan low-density array to predict outcome in advanced Hodgkin's lymphoma using paraffin-embedded samples. Clin Cancer Res 15:1367-1375, 2009
-
(2009)
Clin Cancer Res
, vol.15
, pp. 1367-1375
-
-
Sánchez-Espiridión, B.1
Sánchez-Aguilera, A.2
Montalbán, C.3
-
132
-
-
77949345555
-
Tumor-associated macrophages and survival in classic Hodgkin's lymphoma
-
Steidl C, Lee T, Shah SP, et al: Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med 362:875-885, 2010
-
(2010)
N Engl J Med
, vol.362
, pp. 875-885
-
-
Steidl, C.1
Lee, T.2
Shah, S.P.3
-
133
-
-
33750598940
-
Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: A clinicopathologic study
-
DOI 10.1200/JCO.2006.06.5342
-
Asano N, Oshiro A, Matsuo K, et al: Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: A clinicopathologic study. J Clin Oncol 24:4626-4633, 2006 (Pubitemid 46630961)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.28
, pp. 4626-4633
-
-
Asano, N.1
Oshiro, A.2
Matsuo, K.3
Kagami, Y.4
Ishida, F.5
Suzuki, R.6
Kinoshita, T.7
Shimoyama, Y.8
Tamaru, J.-I.9
Yoshino, T.10
Kitamura, K.11
Fukutani, H.12
Morishima, Y.13
Nakamura, S.14
-
134
-
-
0031043575
-
Activated cytotoxic T cells as prognostic marker in Hodgkin's disease
-
Oudejans JJ, Jiwa NM, Kummer JA, et al: Activated cytotoxic T cells as prognostic marker in Hodgkin's disease. Blood 89:1376-1382, 1997 (Pubitemid 27080002)
-
(1997)
Blood
, vol.89
, Issue.4
, pp. 1376-1382
-
-
Oudejans, J.J.1
Jiwa, N.M.2
Kummer, J.A.3
Ossenkoppele, G.J.4
Van Heerde, P.5
Baars, J.W.6
Kluin, P.M.7
Kluin-Nelemans, J.C.8
Van Diest, P.J.9
Middeldorp, J.M.10
Meijer, C.J.L.M.11
-
135
-
-
0035084021
-
Percentage of activated cytotoxic T-lymphocytes in anaplastic large cell lymphoma and Hodgkin's disease: An independent biological prognostic marker
-
ten Berge RL, Oudejans JJ, Dukers DF, et al: Percentage of activated cytotoxic T-lymphocytes in anaplastic large cell lymphoma and Hodgkin's disease: An independent biological prognostic marker. Leukemia 15:458-464, 2001
-
(2001)
Leukemia
, vol.15
, pp. 458-464
-
-
Ten Berge, R.L.1
Oudejans, J.J.2
Dukers, D.F.3
-
136
-
-
28244446162
-
Tumor-infiltrating cells as a prognostic factor in Hodgkin's lymphoma: A quantitative tissue microarray study in a large retrospective cohort of 267 patients
-
DOI 10.1080/10428190500220654
-
Alvaro-Naranjo T, Lejeune M, Salvadó-Usach MT, et al: Tumor-infiltrating cells as a prognostic factor in Hodgkin's lymphoma: A quantitative tissue microarray study in a large retrospective cohort of 267 patients. Leuk Lymphoma 46:1581-1591, 2005 (Pubitemid 41700991)
-
(2005)
Leukemia and Lymphoma
, vol.46
, Issue.11
, pp. 1581-1591
-
-
Alvaro-Naranjo, T.1
Lejeune, M.2
Salvado-Usach, M.T.3
Bosch-Princep, R.4
Reverter-Branchat, G.5
Jaen-Martinez, J.6
Pons-Ferre, L.E.7
-
137
-
-
38049022492
-
The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression
-
Kelley TW, Pohlman B, Elson P, et al: The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression. Am J Clin Pathol 128:958-965, 2007
-
(2007)
Am J Clin Pathol
, vol.128
, pp. 958-965
-
-
Kelley, T.W.1
Pohlman, B.2
Elson, P.3
-
138
-
-
20044367117
-
Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells
-
DOI 10.1158/1078-0432.CCR-04-1869
-
Alvaro T, Lejeune M, Salvadó MT, et al: Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res 11:1467-1473, 2005 (Pubitemid 40315228)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.4
, pp. 1467-1473
-
-
Alvaro, T.1
Lejeune, M.2
Salvado, M.T.3
Bosch, R.4
Garcia, J.F.5
Jaen, J.6
Banham, A.H.7
Roncador, G.8
Montalban, C.9
Piris, M.A.10
-
139
-
-
40849126992
-
+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma
-
DOI 10.3324/haematol.11702
-
Tzankov A, Meier C, Hirschmann P, et al: Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma. Haematologica 93:193-200, 2008 (Pubitemid 351397707)
-
(2008)
Haematologica
, vol.93
, Issue.2
, pp. 193-200
-
-
Tzankov, A.1
Meier, C.2
Hirschmann, P.3
Went, P.4
Pileri, S.A.5
Dirnhofer, S.6
-
140
-
-
63849185609
-
Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome
-
Chetaille B, Bertucci F, Finetti P, et al: Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome. Blood 113:2765-3775, 2009
-
(2009)
Blood
, vol.113
, pp. 2765-3775
-
-
Chetaille, B.1
Bertucci, F.2
Finetti, P.3
-
141
-
-
0021796995
-
Macrophage-histiocytes in Hodgkin's disease. The relation of peanut-agglutinin-binding macrophage-histiocytes to clinicopathologic presentation and course of disease
-
DOI 10.1002/1097-0142(19850715)56:2<333::AID-CNCR2820560222>3.0. CO;2-0
-
Ree HJ, Kadin ME: Macrophage-histiocytes in Hodgkin's disease: The relation of peanut-agglutinin- binding macrophage-histiocytes to clinico-pathologic presentation and course of disease. Cancer 56:333-338, 1985 (Pubitemid 15031656)
-
(1985)
Cancer
, vol.56
, Issue.2
, pp. 333-338
-
-
Ree, H.J.1
Kadin, M.E.2
-
142
-
-
33745938078
-
Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma
-
DOI 10.1182/blood-2005-12-5125
-
Sánchez-Aguilera A, Montalbán C, de la Cueva P, et al: Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma. Blood 108:662-668, 2006 (Pubitemid 44061368)
-
(2006)
Blood
, vol.108
, Issue.2
, pp. 662-668
-
-
Sanchez-Aguilera, A.1
Montalban, C.2
De La, C.P.3
Sanchez-Verde, L.4
Morente, M.M.5
Garcia-Cosio, M.6
Garcia-Larana, J.7
Bellas, C.8
Provencio, M.9
Romagosa, V.10
Fernandez, D.S.A.11
Menarguez, J.12
Sabin, P.13
Mestre, M.J.14
Mendez, M.15
Fresno, M.F.16
Nicolas, C.17
Piris, M.A.18
Garcia, J.F.19
-
143
-
-
0034019368
-
Improved prognosis of Epstein-Barr virus associated childhood Hodgkin's lymphoma: Study of 47 South African cases
-
DOI 10.1136/jcp.53.3.182
-
Engel M, Essop MF, Close P, et al: Improved prognosis of Epstein-Barr virus associated childhood Hodgkin's lymphoma: Study of 47 South African cases. J Clin Pathol 53:182-186, 2000 (Pubitemid 30163599)
-
(2000)
Journal of Clinical Pathology
, vol.53
, Issue.3
, pp. 182-186
-
-
Engel, M.1
Essop, M.F.2
Close, P.3
Hartley, P.4
Pallesen, G.5
Sinclair-Smith, C.6
-
144
-
-
32544455019
-
Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: A population-based study
-
DOI 10.1200/JCO.2005.02.6310
-
Keegan TH, Glaser SL, Clarke CA, et al: Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: A population-based study. J Clin Oncol 23:7604-7613, 2005 (Pubitemid 46291824)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.30
, pp. 7604-7613
-
-
Keegan, T.H.M.1
Glaser, S.L.2
Clarke, C.A.3
Gulley, M.L.4
Craig, F.E.5
DiGiuseppe, J.A.6
Dorfman, R.F.7
Mann, R.B.8
Ambinder, R.F.9
-
145
-
-
68949088571
-
Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients
-
Diepstra A, van Imhoff GW, Schaapveld M, et al: Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients. J Clin Oncol 27:3815-3821, 2009
-
(2009)
J Clin Oncol
, vol.27
, pp. 3815-3821
-
-
Diepstra, A.1
Van Imhoff, G.W.2
Schaapveld, M.3
-
146
-
-
27144466008
-
Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: A population-based study
-
DOI 10.1182/blood-2004-09-3759
-
Jarrett RF, Stark GL, White J, et al: Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: A population-based study. Blood 106:2444-2451, 2005 (Pubitemid 41510819)
-
(2005)
Blood
, vol.106
, Issue.7
, pp. 2444-2451
-
-
Jarrett, R.F.1
Stark, G.L.2
White, J.3
Angus, B.4
Alexander, F.E.5
Krajewski, A.S.6
Freeland, J.7
Taylor, G.M.8
Taylor, P.R.A.9
-
147
-
-
33747831454
-
The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma
-
DOI 10.1007/s00277-006-0081-9
-
Kwon JM, Park YH, Kang JH, et al: The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma. Ann Hematol 85:463-468, 2006 (Pubitemid 44283113)
-
(2006)
Annals of Hematology
, vol.85
, Issue.7
, pp. 463-468
-
-
Kwon, J.M.1
Park, Y.H.2
Kang, J.H.3
Kim, K.4
Ko, Y.H.5
Ryoo, B.Y.6
Lee, S.S.7
Lee, S.I.8
Koo, H.H.9
Kim, W.S.10
-
148
-
-
85047699635
-
Gene expression profiling defines molecular subtypes of classical Hodgkin's disease
-
DOI 10.1038/sj/onc/1205418
-
Devilard E, Bertucci F, Trempat P, et al: Gene expression profiling defines molecular subtypes of classical Hodgkin's disease. Oncogene 21:3095-3102, 2002 (Pubitemid 34522911)
-
(2002)
Oncogene
, vol.21
, Issue.19
, pp. 3095-3102
-
-
Devilard, E.1
Bertucci, F.2
Trempat, P.3
Bouabdallah, R.4
Loriod, B.5
Giaconia, A.6
Brousset, P.7
Granjeaud, S.8
Nguyen, C.9
Birnbaum, D.10
Birg, F.11
Houlgatte, R.12
Xerri, L.13
-
149
-
-
0024422264
-
Relationship of histopathologic features to survival and relapse in
-
MacLennan KA, Bennett MH, Tu A, et al: Relationship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin's disease: A study of 1659 patients. Cancer 64:1686-1693, 1989 (Pubitemid 19251140)
-
(1989)
Cancer
, vol.64
, Issue.8
, pp. 1686-1693
-
-
MacLennan, K.A.1
Bennett, M.H.2
Tu, A.3
Vaughan, H.B.4
Easterling, M.J.5
Vaughan, H.G.6
Jelliffe, A.M.7
-
150
-
-
0028363275
-
Histopathologic grading of nodular sclerosis Hodgkin's disease: Lack of prognostic significance in 254 surgically staged patients
-
DOI 10.1002/1097-0142(19940715)74:2<708::AID-CNCR2820740226>3.0. CO;2-7
-
Hess JL, Bodis S, Pinkus G, et al: Histopathologic grading of nodular sclerosis Hodgkin's disease: Lack of prognostic significance in 254 surgically staged patients. Cancer 74:708-714, 1994 (Pubitemid 24217638)
-
(1994)
Cancer
, vol.74
, Issue.2
, pp. 708-714
-
-
Hess, J.L.1
Bodis, S.2
Pinkus, G.3
Silver, B.4
Mauch, P.5
-
151
-
-
0031040059
-
Disappearance of prognostic significance of histopathological grading of nodular sclerosing Hodgkin's disease for unselected patients, 1972-92
-
van Spronsen DJ, Vrints LW, Hofstra G, et al: Disappearance of prognostic significance of histopathological grading of nodular sclerosing Hodgkin's disease for unselected patients, 1972-92. Br J Haematol 96:322-327, 1997
-
(1997)
Br J Haematol
, vol.96
, pp. 322-327
-
-
Van Spronsen, D.J.1
Vrints, L.W.2
Hofstra, G.3
-
152
-
-
0024573723
-
Increasing interdependency of prognosis- And therapy-related factors in Hodgkin's disease
-
Gobbi PG, Cavalli C, Federico M, et al: Increasing interdependency of prognosis- and therapy-related factors in Hodgkin's disease. Acta Haematol 81:34-40, 1989 (Pubitemid 19079221)
-
(1989)
Acta Haematologica
, vol.81
, Issue.1
, pp. 34-40
-
-
Gobbi, P.G.1
Cavalli, C.2
Federico, M.3
Lombardo, M.4
Bertoloni, D.5
Grignani, G.E.6
Pieresca, C.7
Ascari, E.8
Mauri, C.9
-
153
-
-
0027880294
-
Infiltration of eosinophils in Hodgkin's disease involved lymph nodes predicts prognosis
-
Enblad G, Sundstrom C, Glimelius B: Infiltration of eosinophils in Hodgkin's disease involved lymph nodes predicts prognosis. Hematol Oncol 11:187-193, 1993 (Pubitemid 24097112)
-
(1993)
Hematological Oncology
, vol.11
, Issue.4
, pp. 187-193
-
-
Enblad, G.1
Sundstrom, C.2
Glimelius, B.3
-
154
-
-
0027450261
-
Hodgkin disease in patients 60 years of age or older: Histologic and clinical features of advanced-stage disease - The Cancer and Leukemia Group B
-
Mir R, Anderson J, Strauchen J, et al: Hodgkin disease in patients 60 years of age or older: Histologic and clinical features of advanced-stage disease - The Cancer and Leukemia Group B. Cancer 71:1857-1866, 1993
-
(1993)
Cancer
, vol.71
, pp. 1857-1866
-
-
Mir, R.1
Anderson, J.2
Strauchen, J.3
-
155
-
-
0034839397
-
Tissue eosinophilia in relation to immunopathological and clinical characteristics in Hodgkin's disease
-
Axdorph U, Porwit-MacDonald A, Grimfors G, et al: Tissue eosinophilia in relation to immuno-pathological and clinical characteristics in Hodgkin's disease. Leuk Lymphoma 42:1055-1065, 2001 (Pubitemid 32827528)
-
(2001)
Leukemia and Lymphoma
, vol.42
, Issue.5
, pp. 1055-1065
-
-
Axdorph, U.1
Porwit-Macdonald2
Grimfors, G.3
Bjorkholm, M.4
-
156
-
-
0036400296
-
Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma
-
DOI 10.1046/j.1365-2141.2002.03768.x
-
Molin D, Edstrom A, Glimelius I, et al: Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma. Br J Haematol 119:122-124, 2002 (Pubitemid 35176509)
-
(2002)
British Journal of Haematology
, vol.119
, Issue.1
, pp. 122-124
-
-
Molin, D.1
Edstrom, A.2
Glimelius, I.3
Glimelius, B.4
Nilsson, G.5
Sundstrom, C.6
Enblad, G.7
-
157
-
-
67749106603
-
Prognostic significance of new immunohistochemical markers in refractory classical Hodgkin lymphoma: A study of 59 cases
-
Canioni D, Deau-Fischer B, Taupin P, et al: Prognostic significance of new immunohistochemical markers in refractory classical Hodgkin lymphoma: A study of 59 cases. PLoS One 4:e6341, 2009
-
(2009)
PLoS One
, vol.4
-
-
Canioni, D.1
Deau-Fischer, B.2
Taupin, P.3
-
158
-
-
0020083643
-
Hodgkin's disease: A clinicopathologic study of 659 cases
-
Colby TV, Hoppe RT, Warnke RA: Hodgkin's disease: A clinicopathologic study of 659 cases. Cancer 49:1848-1858, 1982
-
(1982)
Cancer
, vol.49
, pp. 1848-1858
-
-
Colby, T.V.1
Hoppe, R.T.2
Warnke, R.A.3
-
159
-
-
77956544224
-
A molecular risk score based on four functional pathways for advanced classical Hodgkin lymphoma
-
Sánchez-Espiridión B, Montalbán C, López A, et al: A molecular risk score based on four functional pathways for advanced classical Hodgkin lymphoma. Blood 116:e12-e17, 2010
-
(2010)
Blood
, vol.116
-
-
Sánchez-Espiridión, B.1
Montalbán, C.2
López, A.3
-
160
-
-
24744438473
-
Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)
-
Farinha P, Masoudi H, Skinnider BF, et al: Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood 106:2169-2174, 2005
-
(2005)
Blood
, vol.106
, pp. 2169-2174
-
-
Farinha, P.1
Masoudi, H.2
Skinnider, B.F.3
-
161
-
-
65249135978
-
Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma
-
Schreck S, Friebel D, Buettner M, et al: Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma. Hematol Oncol 27:31-39, 2009
-
(2009)
Hematol Oncol
, vol.27
, pp. 31-39
-
-
Schreck, S.1
Friebel, D.2
Buettner, M.3
-
162
-
-
70350238332
-
Differences in tumor regulatory T-cell localization and activation status impact patient outcome
-
Ménétrier-Caux C, Gobert M, Caux C: Differences in tumor regulatory T-cell localization and activation status impact patient outcome. Cancer Res 69:7895-7898, 2009
-
(2009)
Cancer Res
, vol.69
, pp. 7895-7898
-
-
Ménétrier-Caux, C.1
Gobert, M.2
Caux, C.3
-
163
-
-
38949101159
-
Tumor-infiltrated immune response correlates with alterations in the apoptotic and cell cycle pathways in Hodgkin and Reed-Sternberg cells
-
DOI 10.1158/1078-0432.CCR-07-1246
-
Alvaro T, Lejeune M, García JF, et al: Tumor-infiltrated immune response correlates with alterations in the apoptotic and cell cycle pathways in Hodgkin and Reed-Sternberg cells. Clin Cancer Res 14:685-691, 2008 (Pubitemid 351231148)
-
(2008)
Clinical Cancer Research
, vol.14
, Issue.3
, pp. 685-691
-
-
Alvaro, T.1
Lejeune, M.2
Garcia, J.F.3
Salvado, M.T.4
Lopez, C.5
Bosch, R.6
Jaen, J.7
Escriva, P.8
Pons, L.E.9
-
165
-
-
0027717253
-
Relation of follicular dendritic reticulum cells to Reed-Sternberg cells of Hodgkin's disease with emphasis on the expression of CD21 antigen
-
Delsol G, Meggetto F, Brousset P, et al: Relation of follicular dendritic reticulum cells to Reed-Sternberg cells of Hodgkin's disease with emphasis on the expression of CD21 antigen. Am J Pathol 142:1729-1738, 1993 (Pubitemid 24057067)
-
(1993)
American Journal of Pathology
, vol.142
, Issue.6
, pp. 1729-1738
-
-
Delsol, G.1
Meggetto, F.2
Brousset, P.3
Cohen-Knafo, E.4
Saati, T.A.5
Rochaix, P.6
Gorguet, B.7
Rubin, B.8
Voigt, J.-J.9
Chittal, S.10
-
166
-
-
0028308854
-
Follicular dendritic cells have prognostic relevance in Hodgkin's disease
-
Alavaikko MJ, Blanco G, Aine R, et al: Follicular dendritic cells have prognostic relevance in Hodgkin's disease. Am J Clin Pathol 101:761-767, 1994 (Pubitemid 24169313)
-
(1994)
American Journal of Clinical Pathology
, vol.101
, Issue.6
, pp. 761-767
-
-
Alavaikko, M.J.1
Blanco, G.2
Aine, R.3
Lehtinen, T.4
Fellbaum, C.5
Taskinen, P.J.6
Sarpola, A.7
Hansmann, M.-L.8
-
167
-
-
0031808140
-
Prognostic value of follicular dendritic cells in nodular sclerosing Hodgkin's disease
-
DOI 10.1046/j.1365-2559.1998.t01-1-00418.x
-
Baur AS, Meugé-Moraw C, Michel G, et al: Prognostic value of follicular dendritic cells in nodular sclerosing Hodgkin's disease. Histopathology 32:512-520, 1998 (Pubitemid 28277551)
-
(1998)
Histopathology
, vol.32
, Issue.6
, pp. 512-520
-
-
Baur, A.S.1
Meuge-Moraw, C.2
Michel, G.3
Delacretaz, F.4
-
168
-
-
0031018030
-
Epstein-Barr virus-associated Hodgkin's disease: Epidemiologic characteristics in international data
-
DOI 10.1002/(SICI)1097-0215(19970207)70:4<375::AID-IJC1>3.0.CO;2-T
-
Glaser SL, Lin RJ, Stewart SL, et al: Epstein- Barr virus-associated Hodgkin's disease: Epidemiologic characteristics in international data. Int J Cancer 70:375-382, 1997 (Pubitemid 27107262)
-
(1997)
International Journal of Cancer
, vol.70
, Issue.4
, pp. 375-382
-
-
Glaser, S.L.1
Lin, R.J.2
Stewart, S.L.3
Ambinder, R.F.4
Jarrett, R.F.5
Brousset, P.6
Pallesen, G.7
Gulley, M.L.8
Khan, G.9
O'Grady, J.10
Hummel, M.11
Preciado, M.V.12
Knecht, H.13
Chan, J.K.C.14
Claviez, A.15
-
169
-
-
0030744416
-
Lack of correlation between EBV serology and presence of EBV in the Hodgkin and Reed-Sternberg cells of patients with Hodgkin's disease
-
DOI 10.1002/(SICI)1097-0215(19970729)72:3<394::AID-IJC3>3.0.CO;2-K
-
Enblad G, Sandvej K, Lennette E, et al: Lack of correlation between EBV serology and presence of EBV in the Hodgkin and Reed-Sternberg cells of patients with Hodgkin's disease. Int J Cancer 72: 394-397, 1997 (Pubitemid 27325863)
-
(1997)
International Journal of Cancer
, vol.72
, Issue.3
, pp. 394-397
-
-
Enblad, G.1
Sandvej, K.2
Lennette, E.3
Sundstrom, C.4
Klein, G.5
Glimelius, B.6
Pallesen, G.7
-
170
-
-
0030801898
-
Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr Virus-latent membrane protein 1 expression
-
Morente MM, Piris MA, Abraira V, et al: Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression. Blood 90:2429-2436, 1997 (Pubitemid 27392727)
-
(1997)
Blood
, vol.90
, Issue.6
, pp. 2429-2436
-
-
Morente, M.M.1
Piris, M.A.2
Abraira, V.3
Acevedo, A.4
Aguilera, B.5
Bellas, C.6
Fraga, M.7
Garcia-Del-Moral, R.8
Gomez-Marcos, F.9
Menarguez, J.10
Oliva, H.11
Sanchez-Beato, M.12
Montalban, C.13
-
171
-
-
0031777592
-
Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients
-
Warzocha K, Bienvenu J, Ribeiro P, et al: Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients. Br J Cancer 77:2357-2362, 1998 (Pubitemid 28263966)
-
(1998)
British Journal of Cancer
, vol.77
, Issue.12
, pp. 2357-2362
-
-
Warzocha, K.1
Bienvenu, J.2
Ribeiro, P.3
Moullet, I.4
Dumontet, C.5
Neidhardt-Berard, E.M.6
Coiffier, B.7
Salles, G.8
-
172
-
-
21344435055
-
Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: Potential for a prognostic factor
-
DOI 10.1158/0008-5472.CAN-05-0100
-
Weihrauch MR, Manzke O, Beyer M, et al: Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: Potential for a prognostic factor. Cancer Res 65:5516-5519, 2005 (Pubitemid 40911150)
-
(2005)
Cancer Research
, vol.65
, Issue.13
, pp. 5516-5519
-
-
Weihrauch, M.R.1
Manzke, O.2
Beyer, M.3
Haverkamp, H.4
Diehl, V.5
Bohlen, H.6
Wolf, J.7
Schultze, J.L.8
-
173
-
-
0025833281
-
Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease
-
Gause A, Pohl C, Tschiersch A, et al: Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease. Blood 77:1983-1988, 1991
-
(1991)
Blood
, vol.77
, pp. 1983-1988
-
-
Gause, A.1
Pohl, C.2
Tschiersch, A.3
-
174
-
-
0027162928
-
Serum levels of soluble interleukin-2 receptor in Hodgkin disease: Relationship with clinical stage, tumor burden, and treatment outcome
-
Ambrosetti A, Nadali G, Vinante F, et al: Serum levels of soluble interleukin-2 receptor in Hodgkin disease: Relationship with clinical stage, tumor burden, and treatment outcome. Cancer 72: 201-206, 1993 (Pubitemid 23182073)
-
(1993)
Cancer
, vol.72
, Issue.1
, pp. 201-206
-
-
Ambrosetti, A.1
Nadali, G.2
Vinante, F.3
Carlini, S.4
Veneri, D.5
Todeschini, G.6
Morosato, L.7
De Sabata, D.8
Chilosi, M.9
Maggi, E.10
Parronchi, P.11
Romagnani, S.12
Semenzato, G.13
Perona, G.14
Pizzolo, G.15
-
175
-
-
0029086042
-
Soluble ICAM-1 in Hodgkin's disease: A promising independent predictive marker for survival
-
Christiansen I, Enblad G, Kalkner KM, et al: Soluble ICAM-1 in Hodgkin's disease: A promising independent predictive marker for survival. Leuk Lymphoma 19:243-251, 1995
-
(1995)
Leuk Lymphoma
, vol.19
, pp. 243-251
-
-
Christiansen, I.1
Enblad, G.2
Kalkner, K.M.3
-
176
-
-
0031840361
-
Soluble vascular cell adhesion molecule-1 (sVCAM-1) is an independent prognostic marker in Hodgkin's disease
-
DOI 10.1046/j.1365-2141.1998.00840.x
-
Christiansen I, Sundström C, Enblad G, et al: Soluble vascular cell adhesion molecule-1 (sVCAM-1) is an independent prognostic marker in Hodgkin's disease. Br J Haematol 102:701-709, 1998 (Pubitemid 28387052)
-
(1998)
British Journal of Haematology
, vol.102
, Issue.3
, pp. 701-709
-
-
Christiansen, I.1
Sundstrom, C.2
Enblad, G.3
Totterman, T.H.4
-
177
-
-
0037324651
-
Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling
-
DOI 10.1172/JCI200316624
-
Küppers R, Klein U, Schwering I, et al: Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. J Clin Invest 111:529-537, 2003 (Pubitemid 36228010)
-
(2003)
Journal of Clinical Investigation
, vol.111
, Issue.4
, pp. 529-537
-
-
Kuppers, R.1
Klein, U.2
Schwering, I.3
Distler, V.4
Brauninger, A.5
Cattoretti, G.6
Tu, Y.7
Stolovitzky, G.A.8
Califano, A.9
Hansmann, M.-L.10
Dalla-Favera, R.11
-
178
-
-
53349174860
-
Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis
-
Brune V, Tiacci E, Pfeil I, et al: Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. J Exp Med 205:2251-2268, 2008
-
(2008)
J Exp Med
, vol.205
, pp. 2251-2268
-
-
Brune, V.1
Tiacci, E.2
Pfeil, I.3
-
179
-
-
57149089307
-
Stromal gene signatures in large B-cell lymphomas
-
Lenz G, Wright G, Dave SS, et al: Stromal gene signatures in large B-cell lymphomas. N Engl J Med 359:2313-2323, 2008
-
(2008)
N Engl J Med
, vol.359
, pp. 2313-2323
-
-
Lenz, G.1
Wright, G.2
Dave, S.S.3
-
180
-
-
78649859816
-
Vascularization predicts overall survival and risk of transformation in follicular lymphoma
-
Farinha P, Kyle A, Minchinton A, et al: Vascularization predicts overall survival and risk of transformation in follicular lymphoma. Haematologica 95: 2157-2160, 2010
-
(2010)
Haematologica
, vol.95
, pp. 2157-2160
-
-
Farinha, P.1
Kyle, A.2
Minchinton, A.3
-
181
-
-
77649206608
-
Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma
-
Iqbal J, Weisenburger DD, Greiner TC, et al: Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood 115: 1026-1036
-
Blood
, vol.115
, pp. 1026-1036
-
-
Iqbal, J.1
Weisenburger, D.D.2
Greiner, T.C.3
-
182
-
-
27744582416
-
Protein expression pattern distinguishes different lymphoid neoplasms
-
DOI 10.1002/pmic.200401286
-
Fujii K, Kondo T, Yokoo H, et al: Protein expression pattern distinguishes different lymphoid neoplasms. Proteomics 5:4274-4286, 2005 (Pubitemid 41626095)
-
(2005)
Proteomics
, vol.5
, Issue.16
, pp. 4274-4286
-
-
Fujii, K.1
Kondo, T.2
Yokoo, H.3
Yamada, T.4
Matsuno, Y.5
Iwatsuki, K.6
Hirohashi, S.7
-
183
-
-
33947407619
-
Differential protein expression patterns obtained by mass spectrometry can aid in the diagnosis of Hodgkin's disease
-
Carvalho PC, Carvalho Mda G, Degrave W, et al: Differential protein expression patterns obtained by mass spectrometry can aid in the diagnosis of Hodgkin's disease. J Exp Ther Oncol 6:137-145, 2007 (Pubitemid 46449260)
-
(2007)
Journal of Experimental Therapeutics and Oncology
, vol.6
, Issue.2
, pp. 137-145
-
-
Carvalho, P.C.1
Carvalho, M.D.G.C.2
Degrave, W.3
Lilla, S.4
De Nucci, G.5
Fonseca, R.6
Spector, N.7
Musacchio, J.8
Domont, G.B.9
-
184
-
-
41949122480
-
MicroRNA expression profiling in classic Hodgkin lymphoma
-
Navarro A, Gaya A, Martinez A, et al: MicroRNA expression profiling in classic Hodgkin lymphoma. Blood 111:2825-2832, 2008
-
(2008)
Blood
, vol.111
, pp. 2825-2832
-
-
Navarro, A.1
Gaya, A.2
Martinez, A.3
-
185
-
-
70449500709
-
Regulation of JAK2 by miR-135a: Prognostic impact in classic Hodgkin lymphoma
-
Navarro A, Diaz T, Martinez A, et al: Regulation of JAK2 by miR-135a: Prognostic impact in classic Hodgkin lymphoma. Blood 114:2945-2951, 2009
-
(2009)
Blood
, vol.114
, pp. 2945-2951
-
-
Navarro, A.1
Diaz, T.2
Martinez, A.3
-
186
-
-
77949463615
-
Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma
-
Younes A: Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program 507-519, 2009
-
(2009)
Hematology Am Soc Hematol Educ Program
, pp. 507-519
-
-
Younes, A.1
-
187
-
-
0038345400
-
A pilot study of rituximab in patients with recurrent, classic Hodgkin disease
-
DOI 10.1002/cncr.11511
-
Younes A, Romaguera J, Hagemeister F, et al: A pilot study of rituximab in patients with recurrent, classic Hodgkin disease. Cancer 98:310-314, 2003 (Pubitemid 36828455)
-
(2003)
Cancer
, vol.98
, Issue.2
, pp. 310-314
-
-
Younes, A.1
Romaguera, J.2
Hagemeister, F.3
McLaughlin, P.4
Rodriguez, M.A.5
Fiumara, P.6
Goy, A.7
Jeha, S.8
Manning Jr., J.T.9
Jones, D.10
Abruzzo, L.V.11
Medeiros, L.J.12
-
188
-
-
39049155001
-
Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma
-
DOI 10.1002/cncr.23237
-
Oki Y, Pro B, Fayad LE, et al: Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma. Cancer 112:831-836, 2008 (Pubitemid 351240577)
-
(2008)
Cancer
, vol.112
, Issue.4
, pp. 831-836
-
-
Oki, Y.1
Pro, B.2
Fayad, L.E.3
Romaguera, J.4
Samaniego, F.5
Hagemeister, F.6
Neelapu, S.7
McLaughlin, P.8
Goy, A.9
Younes, A.10
-
189
-
-
38049162295
-
Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: Long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG)
-
Schulz H, Rehwald U, Morschhauser F, et al: Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: Long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG). Blood 111:109-111, 2008
-
(2008)
Blood
, vol.111
, pp. 109-111
-
-
Schulz, H.1
Rehwald, U.2
Morschhauser, F.3
-
190
-
-
0037438710
-
+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: Results of a phase 2 trial of the German Hodgkin Lymphoma Study Group
-
DOI 10.1182/blood.V101.2.420
-
Rehwald U, Schulz H, Reiser M, et al: Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: Results of a phase 2 trial of the German Hodgkin Lymphoma Study Group. Blood 101:420-424, 2003 (Pubitemid 36077558)
-
(2003)
Blood
, vol.101
, Issue.2
, pp. 420-424
-
-
Rehwald, U.1
Schulz, H.2
Reiser, M.3
Sieber, M.4
Staak, J.O.5
Morschhauser, F.6
Driessen, C.7
Rudiger, T.8
Muller-Hermelink, K.9
Diehl, V.10
Engert, A.11
-
191
-
-
66149155829
-
Experience with 90Y-ibritumomab tiuxetan for relapsed classical Hodgkin lymphoma
-
Younes A, Wong F: Experience with 90Y-ibritumomab tiuxetan for relapsed classical Hodgkin lymphoma. Ann Oncol 20:1147-1148, 2009
-
(2009)
Ann Oncol
, vol.20
, pp. 1147-1148
-
-
Younes, A.1
Wong, F.2
-
192
-
-
34547844167
-
A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphoma
-
DOI 10.1093/annonc/mdm114
-
Leonard JP, Friedberg JW, Younes A, et al: A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphoma. Ann Oncol 18:1216-1223, 2007 (Pubitemid 47244369)
-
(2007)
Annals of Oncology
, vol.18
, Issue.7
, pp. 1216-1223
-
-
Leonard, J.P.1
Friedberg, J.W.2
Younes, A.3
Fisher, D.4
Gordon, L.I.5
Moore, J.6
Czuczman, M.7
Miller, T.8
Stiff, P.9
Cheson, B.D.10
Forero-Torres, A.11
Chieffo, N.12
McKinney, B.13
Finucane, D.14
Molina, A.15
-
193
-
-
33845786517
-
Heterogeneous CD52 expression among hematologic neoplasms: Implications for the use of alemtuzumab (CAMPATH-1H)
-
DOI 10.1158/1078-0432.CCR-06-1275
-
Rodig SJ, Abramson JS, Pinkus GS, et al: Heterogeneous CD52 expression among hematologic neoplasms: Implications for the use of alemtuzumab (CAMPATH-1H). Clin Cancer Res 12: 7174-7179, 2006 (Pubitemid 44974519)
-
(2006)
Clinical Cancer Research
, vol.12
, Issue.23
, pp. 7174-7179
-
-
Rodig, S.J.1
Abramson, J.S.2
Pinkus, G.S.3
Treon, S.P.4
Dorfman, D.M.5
Dong, H.Y.6
Shipp, M.A.7
Kutok, J.L.8
-
194
-
-
34447573999
-
Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma
-
DOI 10.1200/JCO.2006.07.8972
-
Ansell SM, Horwitz SM, Engert A, et al: Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma. J Clin Oncol 25:2764-2769, 2007 (Pubitemid 47123185)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.19
, pp. 2764-2769
-
-
Ansell, S.M.1
Horwitz, S.M.2
Engert, A.3
Khan, K.D.4
Lin, T.5
Strair, R.6
Keler, T.7
Graziano, R.8
Blanset, D.9
Yellin, M.10
Fischkoff, S.11
Assad, A.12
Borchmann, P.13
-
195
-
-
76049122850
-
Intracellular activation of SGN-35, a potent anti- CD30 antibody-drug conjugate
-
Okeley NM, Miyamoto JB, Zhang X, et al: Intracellular activation of SGN-35, a potent anti- CD30 antibody-drug conjugate. Clin Cancer Res 16:888-897, 2010
-
(2010)
Clin Cancer Res
, vol.16
, pp. 888-897
-
-
Okeley, N.M.1
Miyamoto, J.B.2
Zhang, X.3
-
196
-
-
79955871242
-
Multiple complete responses in a phase 1 dose-escalation study of the antibody-drug conjugate SGN-35 in patients with relapsed or refractory CD30-positive lymphomas
-
Presented at the abstr 1006
-
Younes A, Forero-Torres A, Bartlett NL, et al: Multiple complete responses in a phase 1 dose-escalation study of the antibody-drug conjugate SGN-35 in patients with relapsed or refractory CD30-positive lymphomas. Presented at the Annual Meeting of the American Society of Hematology, San Francisco, CA, December 6-9, 2008 (abstr 1006)
-
Annual Meeting of the American Society of Hematology, San Francisco, CA, December 6-9, 2008
-
-
Younes, A.1
Forero-Torres, A.2
Bartlett, N.L.3
-
197
-
-
24944458177
-
Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL-R1 and TRAIL-R2 in primary and cultured lymphoma cells: Induction of apoptosis and enhancement of doxorubicin- And bortezomib-induced cell death
-
DOI 10.1111/j.1365-2141.2005.05656.x
-
Georgakis GV, Li Y, Humphreys R, et al: Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL-R1 and TRAIL-R2 in primary and cultured lymphoma cells: Induction of apoptosis and enhancement of doxorubicin- and bortezomib-induced cell death. Br J Haematol 130: 501-510, 2005 (Pubitemid 43899752)
-
(2005)
British Journal of Haematology
, vol.130
, Issue.4
, pp. 501-510
-
-
Georgakis, G.V.1
Li, Y.2
Humphreys, R.3
Andreeff, M.4
O'Brien, S.5
Younes, M.6
Carbone, A.7
Albert, V.8
Younes, A.9
-
198
-
-
50949133383
-
The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells
-
Luqman M, Klabunde S, Lin K, et al: The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells. Blood 112:711-720, 2008
-
(2008)
Blood
, vol.112
, pp. 711-720
-
-
Luqman, M.1
Klabunde, S.2
Lin, K.3
-
199
-
-
79955834951
-
MTOR inhibition for relapsed or refractory Hodgkin lymphoma: Promising single agent activity with everolimus (RAD001)
-
Presented at the abstr 2555
-
Johnston PB, Ansell SM, Colgan JP, et al: MTOR inhibition for relapsed or refractory Hodgkin lymphoma: Promising single agent activity with everolimus (RAD001). Presented at the Annual Meeting of the American Society of Hematology, Atlanta, GA, December 8-11, 2007 (abstr 2555)
-
Annual Meeting of the American Society of Hematology, Atlanta, GA, December 8-11, 2007
-
-
Johnston, P.B.1
Ansell, S.M.2
Colgan, J.P.3
-
200
-
-
2442549643
-
Induction of Cell Cycle Arrest and Apoptosis by the Proteasome Inhibitor PS-341 in Hodgkin Disease Cell Lines Is Independent of Inhibitor of Nuclear Factor-kappaB Mutations or Activation of the CD30, CD40, and RANK Receptors
-
DOI 10.1158/1078-0432.CCR-03-0494
-
Zheng B, Georgakis GV, Li Y, et al: Induction of cell cycle arrest and apoptosis by the proteasome inhibitor PS-341 in Hodgkin disease cell lines is independent of inhibitor of nuclear factor-kappaB mutations or activation of the CD30, CD40, and RANK receptors. Clin Cancer Res 10:3207-3215, 2004 (Pubitemid 38619702)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.9
, pp. 3207-3215
-
-
Zheng, B.1
Georgakis, G.V.2
Li, Y.3
Bharti, A.4
McConkey, D.5
Aggarwal, B.B.6
Younes, A.7
-
201
-
-
32644450349
-
Experience with bortezomib for the treatment of patients with relapsed classical Hodgkin lymphoma [2]
-
DOI 10.1182/blood-2005-09-3603
-
Younes A, Pro B, Fayad L: Experience with bortezomib for the treatment of patients with relapsed classical Hodgkin lymphoma. Blood 107: 1731-1732, 2006 (Pubitemid 43242417)
-
(2006)
Blood
, vol.107
, Issue.4
, pp. 1731-1732
-
-
Younes, A.1
Pro, B.2
Fayad, L.3
-
202
-
-
34447566086
-
Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: Cancer and leukemia Group B protocol 50206
-
DOI 10.1080/10428190701411458, PII 780396333
-
Blum KA, Johnson JL, Niedzwiecki D, et al: Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: Cancer and leukemia Group B protocol 50206. Leuk Lymphoma 48:1313-1319, 2007 (Pubitemid 47079358)
-
(2007)
Leukemia and Lymphoma
, vol.48
, Issue.7
, pp. 1313-1319
-
-
Blum, K.A.1
Johnson, J.L.2
Niedzwiecki, D.3
Canellos, G.P.4
Cheson, B.D.5
Bartlett, N.L.6
-
203
-
-
79955841419
-
Vorinostat (suberoylanilide hydroxamic acid) in relapsed or refractory Hodgkin lymphoma: SWOG 0517
-
Presented at the abstr 2574
-
Kirschbaum MH, Goldman BH, Zain JM, et al: Vorinostat (suberoylanilide hydroxamic acid) in relapsed or refractory Hodgkin lymphoma: SWOG 0517. Presented at the Annual Meeting of the American Society of Hematology, Atlanta, GA, December 8-11, 2007 (abstr 2574)
-
Annual Meeting of the American Society of Hematology, Atlanta, GA, December 8-11, 2007
-
-
Kirschbaum, M.H.1
Goldman, B.H.2
Zain, J.M.3
-
204
-
-
51649092609
-
Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines
-
Buglio D, Georgakis GV, Hanabuchi S, et al: Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines. Blood 112:1424-1433, 2008
-
(2008)
Blood
, vol.112
, pp. 1424-1433
-
-
Buglio, D.1
Georgakis, G.V.2
Hanabuchi, S.3
-
205
-
-
70349640680
-
Phase II study of oral panobinostat in patients with relapsed/refractory Hodgkin lymphoma (HL) after high-dose chemotherapy with autologous stem cell transplant
-
suppl 2; abstr 34
-
Younes A, Sureda A, Ben-Yehuda D, et al: Phase II study of oral panobinostat in patients with relapsed/refractory Hodgkin lymphoma (HL) after high-dose chemotherapy with autologous stem cell transplant. Haematologica 94, 2009 (suppl 2; abstr 34)
-
(2009)
Haematologica
, vol.94
-
-
Younes, A.1
Sureda, A.2
Ben-Yehuda, D.3
-
206
-
-
79955869833
-
A Phase II Multicenter Study of Lenalidomide in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (cHL): Preliminary Results
-
Presented at the abstr 2595
-
Fehniger TA, Larson S, Trinkaus K, et al: A Phase II Multicenter Study of Lenalidomide in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (cHL): Preliminary Results. Presented at the Annual Meeting of the American Society of Hematology, San Francisco, CA, December 6-9, 2008 (abstr 2595)
-
Annual Meeting of the American Society of Hematology, San Francisco, CA, December 6-9, 2008
-
-
Fehniger, T.A.1
Larson, S.2
Trinkaus, K.3
-
207
-
-
79955825757
-
Phase II trial of lenalidomide in patients with relapsed or refractory Hodgkin lymphoma
-
Presented at the abstr 3052
-
Kuruvilla J, Taylor D, Wang L, et al: Phase II trial of lenalidomide in patients with relapsed or refractory Hodgkin lymphoma. Presented at the Annual Meeting of the American Society of Hematology, San Francisco, CA, December 6-9, 2008 (abstr 3052)
-
Annual Meeting of the American Society of Hematology, San Francisco, CA, December 6-9, 2008
-
-
Kuruvilla, J.1
Taylor, D.2
Wang, L.3
-
208
-
-
19944426160
-
+ Hodgkin's disease
-
DOI 10.1084/jem.20040890
-
Bollard CM, Aguilar L, Straathof KC, et al: Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease. J Exp Med 200:1623-1633, 2004 (Pubitemid 40094186)
-
(2004)
Journal of Experimental Medicine
, vol.200
, Issue.12
, pp. 1623-1633
-
-
Bollard, C.M.1
Aguilar, L.2
Straathof, K.C.3
Gahn, B.4
Huls, M.H.5
Rousseau, A.6
Sixbey, J.7
Gresik, M.V.8
Carrum, G.9
Hudson, M.10
Dilloo, D.11
Gee, A.12
Brenner, M.K.13
Rooney, C.M.14
Heslop, H.E.15
-
209
-
-
35549008976
-
Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer
-
DOI 10.1182/blood-2007-05-091280
-
Bollard CM, Gottschalk S, Leen AM, et al: Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer. Blood 110: 2838-2845, 2007 (Pubitemid 350006936)
-
(2007)
Blood
, vol.110
, Issue.8
, pp. 2838-2845
-
-
Bollard, C.M.1
Gottschalk, S.2
Leen, A.M.3
Weiss, H.4
Straathof, K.C.5
Carrum, G.6
Khalil, M.7
Wu, M.-F.8
Huls, M.H.9
Chang, C.-C.10
Gresik, M.V.11
Gee, A.P.12
Brenner, M.K.13
Rooney, C.M.14
Heslop, H.E.15
-
210
-
-
46749090038
-
Current role of gemcitabine in the treatment of Hodgkin lymphoma
-
DOI 10.1080/10428190801911704, PII 792198621
-
Oki Y, Younes A: Current role of gemcitabine in the treatment of Hodgkin lymphoma. Leuk Lymphoma 49:883-889, 2008 (Pubitemid 351942740)
-
(2008)
Leukemia and Lymphoma
, vol.49
, Issue.5
, pp. 883-889
-
-
Oki, Y.1
Younes, A.2
-
211
-
-
44949096473
-
Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs
-
Correale P, Del Vecchio MT, La Placa M, et al: Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs. J Immunother 31:132-147, 2008
-
(2008)
J Immunother
, vol.31
, pp. 132-147
-
-
Correale, P.1
Del Vecchio, M.T.2
La Placa, M.3
-
212
-
-
0036498728
-
CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: Associations with presenting features and clinical outcome
-
DOI 10.1200/JCO.20.5.1278
-
Rassidakis GZ, Medeiros LJ, Viviani S, et al: CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: Associations with presenting features and clinical outcome. J Clin Oncol 20:1278-1287, 2002 (Pubitemid 34177434)
-
(2002)
Journal of Clinical Oncology
, vol.20
, Issue.5
, pp. 1278-1287
-
-
Rassidakis, G.Z.1
Medeiros, L.J.2
Viviani, S.3
Bonfante, V.4
Nadali, G.-P.5
Vassilakopoulos, T.P.6
Mesina, O.7
Herling, M.8
Angelopoulou, M.K.9
Giardini, R.10
Chilosi, M.11
Kittas, C.12
McLaughlin, P.13
Rodriguez, M.A.14
Romaguera, J.15
Bonadonna, G.16
Gianni, A.M.17
Pizzolo, G.18
Pangalis, G.A.19
Cabanillas, F.20
Sarris, A.H.21
more..
-
213
-
-
67651092337
-
Circulating clonotypic B cells in classic Hodgkin lymphoma
-
Jones RJ, Gocke CD, Kasamon YL, et al: Circulating clonotypic B cells in classic Hodgkin lymphoma. Blood 113:5920-5926, 2009
-
(2009)
Blood
, vol.113
, pp. 5920-5926
-
-
Jones, R.J.1
Gocke, C.D.2
Kasamon, Y.L.3
-
214
-
-
41349086204
-
A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignancies
-
Bartlett NL, Younes A, Carabasi MH, et al: A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignancies. Blood 111:1848-1854, 2008
-
(2008)
Blood
, vol.111
, pp. 1848-1854
-
-
Bartlett, N.L.1
Younes, A.2
Carabasi, M.H.3
|